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ABSTRACT
1. The first studies of this thesis concerned human
phagocytic cells in vivo as they responded to physical
trauma in an experimental skin abrasion. This showed
the sequence of cellular responses during acute infla¬
mmation and provided quantitative data about the phago¬
cytic cell concentrations at each stage.
2. In an identical skin abrasion several antibiotics,
administered systemically, were assayed. This provided
information about the approximate concentration of each
drug in acute inflammatory exudates.
3. A series of in vitro tests were performed to quantify
the rate at which phagocytic cells, or the various anti¬
biotics, could inactivate Staphylococcus aureus type 42b.
The concentrations used were based on concentrations
measured in vivo (paragraphs 1 and 2 above).
These studies showed that phagocytosis by human
granulocytes is rapid (T-§- = 5.6 minutes), but subsequent
intracellular killing is much slower. In a cell-free
system different antibiotics had variable rates of bacte¬
rial inactivation but, in general, these rates were., of
the same order as the rate of intracellular killing by
normal/
normal human granulocytes. All these experiments
utilised phagocytic cells and antibiotics separately.
4. The most important findings relate to the combined
action of phagocytic cells and antibiotics (particularly
ampicillin). The first clinical studies showed that
during antibiotic therapy the rate of intracellular
killing usually decreased. This effect could not be
demonstrated by adding ampicillin in vitro to granu¬
locytes during their phase of intracellular killing.
However, when ampicillin was administered orally
to 4 healthy subjects there was a decrease of intra¬
cellular killing at 1 and 2 hours. The exact cause
has not been established, but collaborative work indi¬
cates that this may be the result of inhibition by
ampicillin of leucocyte myeloperoxidase and interference
with other enzymes involved in the production or break¬
down of intravacuolar hydrogen peroxide.
5. The importance of these findings is discussed in
the light of a growing awareness that antibiotic therapy
has considerable limitations and may have serious adverse
effects.
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HISTORICAL RRVIEW AND- INTRODUCTION
CHAPT3R 1
"The longer you can look back,
the further you can look forward'1.
(Churchill, 1944).
Bacteria and Infection
In 1864 Louis Pasteur demonstrated that micro¬
organisms present in the atmosphere in low numbers
could multiply in organic solutions such as wine or
milk and cause fermentation (Vallery-Radot 1920). In
the next four decades Robert Eoch and his students
showed that specific micro-organisms caused anthrax,
diptheria, gonorrhoea, pneumococcal pneumonia and
tuberculosis (Guthrie 1958). At the same time Armauer
Hansen in Norway identified the bacillus causing leprosy
(Guthrie 1958).
Immunity
In 1880 Chamberland and Pasteur noticed that
attenuated cholera bacilli were not strongly pathogenic
in chickens and that the birds which recovered then
had immunity to virulent strains of cholera. Further
studies with Bmile Roux showed that attenuated anthrax
strains /
4.
strains could subsequently protect sheep from normally
lethal doses of virulent anthrax bacilli (Reid 1974).
Just as Jenner had observed that previous attacks of
smallpox or infection with cowpox, either natural or
artificial, could lead to long-lasting protection from
smallpox (Jenner 1800), these more recent findings
indicated that the micro-organisms which caused infection
could sometimes be adequately controlled by the body
and that subsequently the patient was immune to further
challenge. Immunisation became an accepted treatment
for infectious disease, particularly effective as a
prophylaxis (Ransom 1896).
Theories of Immunity
Two apparently opposing views were put forward
to explain immunity to infection. The first, the
humoral theory, stated that immunity was dependent on
the host producing antibodies which gave protection by
causing neutralisation of toxins, and agglutination,
precipitation or direct killing of the organisms
(von Behring 1890, Pfeiffer 1394). The other theory,
which emphasized the role of leucocytes, was based on
the studies of Hi ketobnikoff, who had shown that in
a wide range of animal species, the entry of micro¬
organisms would lead to a local accumulation of leuco¬
cytes which could phagocytose the invaders (h'etchniko'ff
1892). Almroth /
Almroth Wright, a Briton, then reconciled these two
theories by demonstrating that serum factors, including
antibodies, could greatly increase phagocytosis (bright
1912).
The 1' '.ran,* of Ivf ccti.cn
Almroth Wright*s dictum 'to stimulate the phago¬
cytes,' was harshly parodied by G-eorge Bernard Shaw
(The Doctors Dilemma, Shaw 1911) (but the medical
literature appears to have largely ignored Shaw's
irony e.g. Stossel 1974). We now understand that active
immunisation can stimulate aspects of phagocytic cell
function which are different from the secondary effects
on these cells following the development of antibodies.
Serum therapy had a rational basis and was linked
to the developing concepts of immunology. The principle
was that an infected patient could have his immunity
enhanced by the administration of an anti-serum active,
against the causative organism, much of the work with
antisera aimed at making these highly specific. However,
quite separate methods of therapy soon took attention
away from the immunological approach.
Joseph Lister (1357) had very rapidly applied
Pasteur's /
Pasteur's studies of the microbial aetiology of
infection to the surgical situation. His method,
based on the anti-bacterial action of solutions of
carbolic acid, "was dramatically effective, when used
locally, in the prevention of wound infections. However,
the toxic action of carbolic precluded its systemic use
in man. In the 1890's the only possible systemic agents
were antisera such as the diphtheria anti-toxin
developed by von Sehring (Reid 1974). Subsequently
Ehrlich realised that many organic compounds could
have a greater toxic effect on micro-organisms than
on the host. In 1912 he showed that neosalvarsan, .an
arsenical, could be a reliable cure for syphilis.
The next milestone in the history of chemotherapy
was the demonstration by Domagk in 1935 of the anti-
streptococcal activity of prontosil, both in vitro and
in vivo. However, the sulphonamide group of drugs such
as prontosil were soon joined by penicillin, developed
for clinical use by Florey, Chain and their colleagues
(Florey et al 1941) based on Sir Alexander Fleeing's
in vitro observations (Fleming 1929). A common factor
between the chemotherapeutic agents and the antibiotics,
apart from their obvious antibacterial properties, is
that their action can be explained without invoking
involvement of the host's immune responses. Thus
antibiotic /
7
antibiotic research and immunological research have
followed different paths in the past three decades.
The clinician tends to ignore immunological aspects
.when he prescribes antibiotic treatment for infection;
his immunologist colleague pays scant attention to
the effects of antibiotics upon his measurements of
host responses.
Modern Antibiotic Therany
The rapid increase in available antibiotics or
chemotherapeutic agents since 1941 meant that virtually
every bacterial species could now be attacked, in vitro
at least. There are some mutant strains which are
highly resistant to all therapeutic agents, but these
may suffer biological disadvantages compared with the
parent organisms (Mitchison 1954). However, Finland
et al (1958) drew attention to the increasing incidence
of drug-resistant gram negative infections which followed
the liberal use of the early antibiotics.
In the 1960's Pseudomonas aeruginosa infection
increased and caused life-threatening infection in
widely different clinical situations. In a retro¬
spective study of this infection, we found that the
three commonest precipitating factors are:- serious
underlying disease processes, previous infection with
other /
8.
other bacteria and treatment with antibiotics, particularly
those with a broad spectrum. (Table 1:1 Raebum, G-eddes
& Murdoch 1969). Bven pseudomonas however, is susceptible
•in vitro to several antibiotics in concentrations which
can be achieved in the serum, Reynolds et al, (1974)
(table 1:2). "In the 1970*s infections with klebsiella
species appear to have increased and to have added to
the overall problem of antibiotic resistance. (Ayliffe,
1973).
The Development of Hew Antibiotics
To some extent the increase in antibiotic resistant
infections has been paralleled by the introduction of
new drugs (G-arrod, 1970). Many of these were chemical
modifications of older antibiotics which increased the
activity against some species (e.g. substituted
penicillins, Batchelor et al 1959). Other new agents
were completely synthetic and were developed for their
ability to block specific metabolic pathways in bacteria
(e.g. trimethoprim, Hitchings 1959). Further antibiotics
were discovered in a systematic search for anti-bacterial
substances produced by individual micro-organisms
(e.g. the cephalosporins, Abraham 1962). It is unlikely
that the list of available antimicrobial agents will
increase so rapidly again as in the past three decades.
Table 1:1
PRUC IP ITAT liTGr FACTORS IN PSRUDOIIONAS INUNCTIONS




Underlying disease 112 96
Associated bacterial infections 106 91
Antibiotics in preceding week 92 77




HIITIMUI-I INHIBITORY COITO5NTRATIONS (M.I.C.)






Polymyxin B 1-16 10
Colistin 2-16 16
Carbenicillin 25 -100 500
G-entamicin 1-10 10
Ticarcillin 12.5 - 50 500




Many microbiologists believe that bacterial
resistance to the existing antibiotics will lead to
an increase in certain bacterial infections (Gould,
1972, Philp and Spencer, 1974), but it is difficult
to distinguish a selective increase of antibiotic
resistant organisms from the other factors which
influence the incidence of infection in a community,
(table 1:3). However, it is a. clinical impression
that the increase of pseudomonas infection during the
1960's could not merely be attributed to the selective
microbiological effects of antibiotics. At that time
there was an increase in the number of severely ill
patients; although their survival was often a medical
triumph, such patients often had an increased suscept¬
ibility to infection. Antibiotics could have subtle
effects on individual patients which alter either their
host defences (Raeburn 1972) or affect the spread of
micro-organisms between different individuals. There
are many possible reasons for an increase in the number
of infections in a community; the first sign of an
adverse influence might be a relative increase of drug
resistant infections.
limitations of antibiotics




SOME FACTORS AFPEOTIIIG- THE D372I0PM2ITT AMD
SPREAD 0? DRUG RESISTANT IITPBGTIOHS
1) The proportion of drug resistant organisms
2) The type of interaction between sensitive and
resistant organisms
3) The effect of antibiotics on other bacteria
4) Host response factors: a) In individual patients
b) In the community
5) The opportunity for spread between different subjec
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patient are summarised in table 1:4. Many studies
show that resistance of the organism to the antibiotic
used in treatment is not the only cause of such failure
(Cluff et al 1968, McCa.be & Jackson 1962, etc.)
Inadequate absorption may occur or there may be poor
distribution Gf the drug to the infected tissues.
Impaired host responses will also predispose to failure
of therapy, although if an active antibiotic can gain
easy access to the organism, there should be measurable




CAUSES 0? FAILURE DUSIffg AIITI3I0IIC TKCRAPY
1) Bacterial resistance to the chosen antibiotic




3) Compromised host responses
a) Locally - eg.
1) Seduced drainage
ii) Persistant foreign bodies




THE SEQUENCE OF HOST RESPONSES TO IlfEECTTOH
Acute Inflammation
Infection occurs when the skin or mucous surfaces
of the host are "breached and micro-organisms enter the
sub-epithelial tissues. The infecting agents or their
products stimulate an inflammatory response by causing
the release from the tissue of endogenous mediators
such as proteases, polypeptides or the pharmacolog¬
ically active amines (Hurley, 1972). During the first
hour of acute inflammation oedema develops as a result
of increased vascular permeability and the resultant
protein exudation (Spector & Willoughby 1972). Shortly
afterwards polymorphonuclear leucocytes migrate into
the area attracted by numerous chemotactic factors
which include certain products of complement
activation, especially C5a (Snyderman et al 1969) and
C 567 (Ward, Cochrane & Mtlller-Eberhard 1955, Lachmann,
Kay & Thompson 1970). There is a formidable list of
other substances chemotactic for neutrophils, the
majority of these being proteins^or polypeptides
(Wilkinson 1974). Eight hours after the onset of
tissue trauma, up to 50/S of the cells of the exudate
are characteristic mononuclear phagocytes and there¬
after these cells predominate. (see appendix p 183 ).
Phagocytosis /
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Phagocytosis and Intracellular Killing
The acute inflammatory reaction rapidly leads
to an accumulation in infected sites of phagocytic
cells, initially neutrophils and then monocytes,
■which can engulf the causative organisms and later
inactivate them. In addition, inflammation provides
certain antibodies and complement components which,
"by opsoninising "bacteria, render them more easily
ingested. It is very important to make a clear
distinction "between the phagocytic process and the
subsequent bactericidal action. Phagocytosis is
usually rapid and depends on energy derived from
glycolysis (Karnovsky 1962). Intracellular killing
of ingested bacteria may be a slower process and derives
the necessary energy from aerobic metabolic pathways;
until killing is complete the host remains at risk of
recrudescence of infection. Prom the studies of Holmes
et al., (1966) and Solberg (1972a)it can be concluded
that phagocytosed organisms are protected from the
effects of antibiotics which tend to remain extra¬
cellular. Intracellular organisms will have already
been confronted by antibody, complement and ether serum
factors. Nevertheless some serum is also necessary
during the phase of intracellular killing.
Varieties /
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Varieties of Phagocytic Cell
A degree of phagocytosis can be achieved by
other cells besides granulocytes and monocytes.
(Rabinovitch 1968). The distinction of granulocytes
and monocytes is the rapidity of phagocytosis and
its extent and also the ability to ingest, preferen¬
tially, particles which have been coated with
immunoglobulin such as IgG- or an IgM - complement
complex. Recent studies have demonstrated that IgG
and C3 receptor sites are present on the cell
surfaces of both mononuclear phagocytes and neutro¬
phils but there are differences in the behaviour of
the receptors (Baenner, 1975).
Phagocytosis can take place in anaerobic
conditions but when the particles are being phago-
cytosed, aerobic metabolic pathways are stimulated
in preparation for the metabolic activities which
accomplish intracellular killing. Confusion occurs
unless it is understood that these aerobic pathways
are 'triggered off' during phagocytosis as an effect
and are not the cause. If, during phagocytosis,
aerobic activity cannot take place then subsequent
intracellular killing is greatly reduced, (Baehner,
1975, Mandell, 1974). There are several syndromes
of decreased intracellular killing in the presence
of normal phagocytosis, (Raeburn 1975), which will
be detailed later on.
Acouix'ed /
Acquired Cellular Immunity in Host Resistance
Two easily distinguishable phagocytic cells
participate in the acute inflammatory response and
it would be strange if their functions were identical.
The presence of mononuclear phagocytes is closely
linked to the development and manifestations of
specific cellular immunity (Mackaness 1970). After
recovery from an infection with any of a variety of
intracellular organisms the macrophages are found to
be morphologically altered, to contain more lysosomal
granules and to show more pinocytosis (van Burth 1972).
These changed macrophe.ges can also show increased
phagocytic activity (Lurie 1964) along with enhanced
microbicidal action (Blanden 1968) and have been
appropriately described as "activated macrophages"
(Mackaness 1970). Some time later the number of activated
macrophages decreases until further infection with the
same organisms occurs whereupon it increases much more
rapidly than after the first challenge due inter alia,
to the action of lymphokines produced by sensitised
lymphocytes (Dumondeet al 1975)* The specificity lies
in the stimulus which leads to activation. After
activation the cells have increased non-specific activity
against many other intracellular organisms.
Antibody in Host Resistance /
19.
Antibody in Host Resistance
The division of lymphocytes into two main groups
of '3' and 'T' cells, is a gross over-simplification
but it is convenient. B cells produce specific anti¬
bacterial antibody which plays a major role in the
continuing host defences against infection. T cells
release lymphokines such as blastogenic factors which
can stimulate B cells thus increasing antibody
form-ation (David 1971), or can activate macrophages
(Dumonde et al 1975). Present evidence indicates that
circulating lymphocytes can permeate most tissues and
would thus reach a site, of bacterial infection. There,
or in local lymph nodes, specifically sensitised B
lymphocytes can differentiate into plasma cells and
produce antibody.
In vitro techniques have shown that normal human
peripheral blood lymphocytes car synthesize IgG and to
a lesser extent IgA and IgM (van Purth et al., 1966).
Similar techniques have been used to stud;/ immunoglobulin
synthesis in other human tissues such as skin (Lai,
1973 )f mucous membrane or parts of the gastro-intestinal
-tract (McClelland et al., 1974).
'General Aspects of Infection and Immunity
The activities of the cells of the immune system
provide a co-ordinated sequence of defences against
infection. Phagocytic cells are active at an early
stage as are a variety of non-specific serum factors
such /
20
such as proteases, lysozyne or transferrin. The phago¬
cytic cell response "becomes predominantly monocytic
after a feu hours and these cells subsequently cooperate
with a variety of lymphoid cells to initiate specific
immune responses. The cellular activities at each phase
are summarised in tablel:5.
21.
lable 1:5
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SUMMARY 0? CHAPTER 1
1. The first approaches to the treatment of microbial
infection -were based on the administration of immune sera,
active immunisation or other means of enhancing immunity.
The host response to infection is initially dependent
on phagocytic cells complemented by a variety of serum
factors. Later a coordinated and specific immune
response provides complementary means of controlling
micro-organisms.
2. Antibiotic therapy appears to control bacterial
infections without the need for stimulation of normal
immune responses. Conventional antibiotic regimes do
not necessarily provide the most useful reinforcement
of the natural host defences.
3. The following chapters summarise a series of studies
to elucidate how antibiotic therapy can best be made to
complement these activities of the immune system.
23.
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PHAGOCYTIC CELL3 IH TUB INITIAL
RESPONSES TO IITEECTIOil
CHAPTER II
"As bees bizz out wi' angry fyke,




Many centuries after Celsus defined the cardinal
signs of inflammation as rubor, tumor, calor & dolor,
(c.A.D. 30) John Hunter (1794) suggested that inflammation
might well be 'salutory* and an important part of the
body's defence against injury. Lister (1358) and Cohnheim
(1832) described the changes occurring during inflammation
and then De Haan (1920) showed that the first leucocytes
in acute inflammatory exudates were granulocytes which,
after the first few hours, were partially replaced by
mononuclear cells. Rebuck & Crowley (1955) described
"kke skin window technique for studying inflammation
in vivo in man but erroneously suggested that the
mononuclear cells present after a few hours were derived
from lymphocytes. The skin window technique has been
used /
25.
used here to examine, in this chapter, the sequence of
the cellular responses and in chapter three the local¬
isation of administered antibiotics, following acute
inflammation induced by minimal physical trauma.
METHODS
Reasons for using the Skin Window technique
The skin window technique provides an accessible
model of the acute inflammatory response and can be
used without danger or undue discomfort to the subject.
The cellular changes seem very similar to those which
occur during acute inflammation in the lungs (Boyd,
1965) or the kidney (Robbins, 1967), For this thesis,
skin window studies provide a practical means of
examining the early relationship between phagocytic
cell activities and antibiotic therapy. In addition,
a variety of serum factors can be examined. Very
recently MacClelland & van Eurth (1975) have measured
immunoglobulins, albumin, lysozyme and complement in
the resultant exudates.
The Skin Window technique
Initial experiments showed that the middle of the
non-dominant forearm was a suitable site for use in the
test and that during each experiment thesubjects could
move/
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move around. The chosen area was shaved and then
cleansed with 70>S alcohol which was allowed to evaporate
completely. Abrasions were, made with a sterile scalpel,
the blade of which was held vertical and gently scraped
from side to side over the tensed, horizontal skin.
An alternative method in which the tensed area was
touched lightly with a high speed rotating sterile
buff (fig. 2:1) proved more rapid, less painful and
gave a more consistent experimental lesion. This
technique was adopted for all the subsequent studies.
The area abraded in each case ranged from 5 x 5mm
square to 5 x 10mm and could most easily be measured
after 24 hours when a scab had formed. At the
macroscopic level these lesions showed a sticky exudate
for three or four hours with mild erythema extending
slightly beyond the lesion. The scab (fig 2:2) became
detached in the subsequent 48 hours to leave a faint
red scar which had faded within a few weeks.
Collection of the exudate
Three different methods of collection were used,
each suitable for a particular purpose.
1. Sterile glass coverslips, 10mm in diameter,
were applied directly to the lesion and covered with
a 12mm filter paper disc, fixed in place with micropore
tape. This method was best for collecting phagocytic
cells /
27.
Figure 2:1 High speed drill and sterile buff being
used to make a skin abrasion.
28
Figure 2:2 Skin abrasion after 24 hours showing
small scab.
29.
cells which adhered to the glass and could then be
subjected to morphological, histochemical or functional
tests. Cells could be collected in this way for up
to 48 hours and while still attached to the glass,
could be cultured in vitro.
2. The lesion was covered with a variety of
chambers (see figs 2:3, a & b), which were fixed
in position using both collodion around the periphery
and pressure applied with a wide strip of micropore.
The chamber was filled with medium 199 which was
usually changed every 6 hours. This method was used
for collecting cells so that the total and differential
leucocyte count could be made.
3. The exudate was taken up by sterile filter
paper discs of either 6 mm or 12 mm diameter placed
directly over the abrasion. These were weighed before
use and immediately afterwards. During contact with
the lesion, the discs were covered with glass microscope
slides (fig. 2:4) which had smoothly ground edges to
avoid chafing. The slides were kept firmly in position
by micropore tape. It was found that the discs did
not move appreciably during the first 3 or 4 hours of
inflammation because of the sticky exudate. Later it
was difficult to keep the discs in place. This method
produced/
30.
Figure 2:3 Two chambers used in method 2. Volumes
were 2.1 ml. for (chamber a) and
0.5 ml. (chamber b).
See appendix 6 page 211
31.
Figure 2:4 Method for collecting exudate on
sterile filter paper discs, covered
by a prepared microscope slide.
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produced samples of exudate varying from 2 to 20mg
in weight which were used for antibiotic assay
(Chapter 3)»
Time of sampling
In these experiments, many factors influenced
the duration of each sampling period. For the study
of phagocytic cells, the limiting factor was the
degree of confluence on the coverslip. If a particular
coverslip was in position for more than 3 hours the
cells were so closely packed that differential counts
could not be performed. For the studies of antibiotics,
at least 1 hours collection was required to have
sufficient exudate for assay.
Other Methods used in Leucocyte Studies
D* Cell counts were performed using the Heubauer
counting chamber and white cell diluent consisting of
1.5$ glacial acetic acid plus 0.01$ gentian violet
(v/v), in distilled water.
ii) Exudate leucocytes adherent to the coverslips
(Method l) were studied as follows
a) The /
* These studies were performed with Miss Wilma Jack,
a third year medical student.
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The coverslips were changed regularly,
dried rapidly by fanning, and fixed in
absolute methanol for 15 minutes. They
were stained for 10-15 minutes (depending
on the density of cells) in Griemsa, diluted
1 in 10 in distilled water and mounted face
uppermost on standard glass microscope slides
using Depex. On these preparations poly¬
morphonuclear leucocytes were easily identi¬
fied, being morphologically identical to the
same cells in the peripheral blood (fig 2:5).
Since the mononuclear cells of the exudate
were often morphologically different from
any leucocyte of the peripheral blood a
series of cytochemical and functional
tests were performed to identify their
origin (Appendix 1). Since these studies
were dependent on maintaining the cell
viability the coverslips were processed
as follows:-
Before removal from the abrasion approximately
0.25 ml. of sterile medium 199 was injected
under the edge of the coverslip.
This made the coverslip float up from the
abrasion/
34.
Figure 2:5 Polymorphonuclear leucocytes in a skin
window preparation at 4 hours ( x 1000).
(Giemsa stain)
35.
abrasion so that it could be gently
lifted from the site with the cells
and the medium on the under surface.
The coverslip was then placed (cells
uppermost) in 50mm petri dishes
containing medium and serum suitable
for the subsequent tests,
RESULTS
Leucocyte Counts in Uorral Exudates
The chamber method (method 2) shows that in hospital
2
controls an abrasion of 25mm can accumulate at least
1 x 10° leucocytes in a 24 hour period. Table 2:1
gives some clinical data and the individual results.
The considerable variation between tests reflects in
part the difficulty in standardising the depth ox the
skin lesion. The degree of reproducibility in one
individual subject xvas not studied. Table 2:2 shows
that during the first six hours the mean hourly number
of cells mobilised was 0.04 x 10^. In suceeding
sampling periods the mean number of cells mobilised per
hour increased.
During the first 2 hours of inflammation there were




TOTAL LEUCOCYTES IF SKIN IJINDOW CHAMBERS
IK HOSPITAL CONTROLS*
Subject As;e Disease * Leuco- Meev-n
—
eytes/ rate/hr
24 hours (X 10v
(xlO")
W.A. 38 Undiagnosed 3.57 0.15
chest pain
G.3. 59 Myocarditis 13.46 0.56
H.B. 25 Coal gas 21.10 0.87
poisoning
A.C. 44 Barbiturate 13.13 0.55
overdose
J.C. 31 Paracetamol 14.17 0.59
overdose
J.I. 54 Hypertension 48.40 2.02
D.J. 20 Aspirin 13.26 0.55
overdose
M.J. 36 Barbiturate. 1.79 0.07
overdose
B.M. 35 Aspirin 1.25 0.05
overdose
W.M. 49 Mercuric 2.90 0.12
chloride
poisoning
C.S . 36 Amitryptiline 2.70 0.11
overdose
MEANS 12.34 0.51
STANDARD ERRORS 4.13 0.17
* All tests performed when patient was ambulant and
about to be discharged.
37.
Table 2; 2
TOTAL LEUCOCYTES IN SKIN WINDOW CHAMBERS
(MEAN MOBILISATION RATE (PER HOUR) DURING
DIFFERENT COLLECTION PERIODS) *
Time of No. of Mean
collection experiments leucocytes/
hour
0 - 6 hours 3 0.04 x 10^
0-12 hours 5 0.15 x 106
0-18 hours 5 0.19 x 106
0-24 hours 11 0.51 x 106
(S.E.M. 0.17)
z
In some subjects the chamber fluid could not be changed
6-hourly and therefore the later cellular influx "was
'diluted'. For the other subjects cell counts at each
period were summated to give overall figures for 0-12,
0 - 18 or 0 - 24 hours.
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was therefore unsatisfactory for counting. However, in
separate experiments, it was possible to count the
total "glass adherent" cells during the first 2 hours
of inflammation from coverslip preparations,
(Method 1).
These numbers and differential counts are shown
separately in Table 2:3. After 2 hours the cells were
too numerous and too confluent on coverslips for
accurate counting.
The Mature of Exudate Cells in Hormal Subjects
Polymorphonuclear leucocytes were, by far, the most
common cells identified in the early stages of inflamma¬
tion. At two hours they comprised over 95$ of the cell
population, falling to 80$ at 4 hours and 60$ at 6 hours.
As Table 2:4 shows, the skin macrophage was the cell
which increased in the preparations as the poly¬
morphonuclear proportion fell. Figure 2:6 shows
the proportions of these two cell types in one indi¬
vidual throughout the first 24 hours. Figures 2:5 & 2:7
shows representative high power fields at different
time periods. lymphocytes were very rarely present
in the coverslip preparations. Since this may have
been an artefact due to the low glass adhesiveness of
lymphocytes, a few preparations of the cells mobilised
into/
Table 2:3
TOTAL LEUCOCYTES ON COVERSLIP PREPARATIONS











B. McC. 28 417 100 0 0
S.R. 31 85 95 2 2
Dv. ¥. 29 106 94 0 6
Th. v. 35 49 94 4 2
MEANS 164 98 0.6 1.4
* 4 normal subjects
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Table 2:4
LEUCOCYTE TYPES PRESENT III SKIN WINDOWS AT VARYING











0-2 95.4 0 4.6
1 ■ i ,»■*. \
fm •• • *
2.1
2-4 79.4 0 20.6 6.0
4-6 60.4 1.4 38.2 lg.3
6-8 53.3 0 46.7 9.-2
8-10 42.7 0 57.3 ii.o
10-24 24.9 1.6 73.5 14.1
Over 24 40.0 0.5 59.5 12.6
* Means of studies on 6 normal subjects
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Figure 2:6 Skin window cell types in one normal
subject during the 24 hour period
following an abrasion.
42.
Figure 2:7 High power view (x 1000) of skin window
cells at 8 hours showing the poly¬
morphonuclears and the skin window
macrophages. (Giemsa)
43.
into skin chambers (method 2) vrere also examined.
These showed very few lymphoid cells, identified
by morphology after Giemsa staining.
Leucocytes in skin windows of various patients
1. Acute leukaemia
Studies were performed on two patients
with acute myeloblastic leukaemia and two
with acute lymphoblastic leukaemia using
method 1. In all four cases there was a
gross diminution in the number of cells
mobilised in 24 hours (table 2:5).
2. Chronic lymphatic leukaemia
Five patients had skin window studies,
primarily to examine the kinetics of anti¬
biotics. However, in the period from 5 to
24 hours coverslips were applied to examine
the cellularity of the response. Accurate
counting was not possible but these patients
in contrast to normals had at least 50^
lymphocytes in the exudate. (Fig. 2:8).
3. Chronic benign neutropenia
One female infant had a skin window




TOTAL GLASS-ADHERENT CELLS IN PATIENTS
WITH ACUTE LEUKAEMIA
Total cellsx
Patient Diagnosis Age in 24 hours
J.D. ALL 58 8 x 10 5
fl.F. ALL 73 5 x 104
J.T. AML 48 5 x 101
J.B. AML 38 18 x 10 2
x All the cells present on a glass coverslip
held in contact for 24 hours after the skin
abrasion were counted. The morphology (Giemsa
stain) was not normal and differential counts
were not attempted. However, a higher proportion
of granulocytes was present than in the peripheral
blood.
45.
Figure 2:8 Skin window preparation from a patient
with chronic lymphatic leukaemia
(3 - 24 hour sample). Note the proportion
of lymphocytes present.
(G-iemsa stain x 550)
46.
count was less than 300/mmy. No cellular
response occurred; in particular shin
window macrophages did not seem to replace
the neutrophils in the reaction. The
peripheral blood count of monocytes was
*Z
about oOO/min at this period.
DISCUSSION
Total Leucocytes in Skin Abrasions
In our hospital control subjects the total leuco¬
cytes counted in chamber fluid over an abrasion
f. £
ranged from 1.3 i 10 to 48.4 x 10 in 2 4 hours
with a mean of 12 x 10^. This figure can be compared
to the findings of Holland et al (1971) in 46 healthy
2
subjects. With an abrasion of roughly 100mm they
g
found a mean mobilisation rate of 76.0 x 10 in 24
6 6
hours and a range from 45 x 10 to 130 x 10 .
Perillie & Pinch (1964) had found that normal subjects
could mobilise 49»2 x 10^ leucocytes in 24 hours to an
2
abrasion of 400mm . After correction for differences
in abrasion size and allowing for their use of serum
in the chambers with its greater chemotactic activity,
these findings and our own are broadly similar.
Leucocyte /
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Leucocyte Types in Skin Abrasions
Our studies "with coverslips on the skin abrasion
showed a gross preponderance of granulocytes in the
first 4 hours, a gradual increase of skin window
macrophages thereafter, and at S hours macrophages
predominated. This finding contrasts sharply with
the skin chamber results of Holland etal. (1971);
their studies showed that the average percentage
of macrophages during 24 hours was between 0 and
100. Perillie & Pinch (1964) reported that poly¬
morphonuclear leucocytes "predominated at all stages"
but did not give figures. Howal (1969) reported
that using a coverslip technique the percentage of
mononuclear cells (not clearly specified) rose to
about 500 at 12 hours. Thus there appears to be a
difference between the type of leucocytes which adhere
to glass and those which enter a skin chamber. Since
cytochemical studies were not performed in our early
skin chamber studies, this aspect remains unclear.
However, both in-skin chambers (Holland et al. 1971,
I r
Perillie & Pinch 1964) and in glass-adherent methods
(Dale & Wolff 1971, Braunsteiner & Schmalzl 1970,
Wulff 1967,) there is a consensus that lymphocytes
are very infrequently seen in skin window inflammatory
exudates. The /
48
The phagocytic cells predominate during the first
24 hours at least. This initial high concentration
of phagocytic cells is logically explained as the
provision of an immediate defense against invading
bacteria.
Concentration of Phagocytic Cells in Skin Window
Exudates
The relative concentration of bacteria and
phagocytes is of importance in determining the rate
of ingestion (van Eurth & van Zwet 1973). Skin chamber
techniques alone do not allow any measurement of
phagocyte concentration since the exudate volume,
grossly diluted with chamber fluid, cannot be
measured. However, by calculations from the mean of
hourly exudate weights found by method 3 (page29)
and the hourly mobilisation rates at different stages
(table 2:2), some approximation to the actual in vivo
concentrations can be deduced (table 2:6). Thus, in
studies with phagocytic cells in vitro it would be
realistic to use concentrations in the range
3.8 x 10^/ml to 5.0 x 10^/ml. These estimations can
be a basis for developing in vitro models of bacteria/
phagocyte interactions which closely resemble the




CALCULATED PHAGOCYTIC CELL CONCENTRATIONS
IN SEEN WINDOW PREPARATIONS351
Hourly cell Calculated cell #
Time count concentration/ml!'
0-6 hours 4 x 1 04 3.8 x 106
0-12 hours 15 x 10^ 1,4 x 10^
0-18 hours 19 x 104 1.8 x 107
0-24 hours 51 x 104 5.0 x 10^
Based, on figures from table 2:2 on an assumed
hourly exudate volume of 10.5 micro litres.
(See text page 48)
50.
Leucocyte Mobilisation in Blood Disorders
Ho attempt has been made to study large numbers
of patients with leukaemia or other haexnatological
disorders. However, the data in table 2:5 is in keeping
with the findings of Holland et al. (1971) and of
Perillie & Pinch (1964) that patients with acute
leukaemia mobilise fewer leucocytes to skin abrasion
sites than healthy controls.
The qualitative findings in patients with chronic
lymphatic leukaemia correspond to those of Eowal
(1969) who found that mononuclear cells in these
exudates were abnormally increased. Our patient
with chronic familial neutropenia was probably unique
and is noteworthy from many points of view including
the presence of leucoagglutinins, (see Hay et al 1976).
However, the gross diminution of the skin window
response and the relative lack of skin window macro¬
phages contrasts with the findings in several types
of neutropenia reported by Dale & Wolff (1971).
Further studies of leucocyte mobilisation in
different disease states are required to determine
for instance whether reduced mobilisation indicates
a need for more active therapy of any infection than
would otherwise be used.
51.
SUMMARY 0? CHAPTER 2
6U p to 48 x 10 phagocytic cells can he mobilised.
2
into an experimental skin lesion of 25mm area, during
the first 24 hours of inflammation as measured in skin
chambers. The coverslip method shows that these cells
are initially almost entirely polymorphonuclear
leucocytes but that after 6 hours the mononuclear
phagocytes increase to become the predominant cell.
Three patients with acute leukaemia had gross
diminution of the inflammatory responses to an extent
which would be likely to predispose to infection.
Although five patients with chronic lymphatic leukaemia
had a reasonable cellular response (not accurately
estimated), the leukaeinic lymphoid cells could be seen
in the exudate as well as normal neutrophils and skin
window macrophages. A patient with congenital neutro¬
penia had gross reduction of both types of phagocytic
cell in the exudate.
These findings provide a basis for examining the
antibacterial action of phagocytic cells in vitro, in
concentrations similar to those achieved during in vivo
inflammation.
52
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AiTTIBIQTICS U THT INFLAMMATORY RESPONSE
CHAPTER 3
i
" it occurred to me that decomposition
in the injured part might he avoided by
applying some material capable of
destroying the life of the floating particles"
(Joseph Lister, 1867).
INTRODUCTION
The efficiency of phagocytic cells is initially
determined by their ability to move rapidly to areas
of infection. Likewise antibiotics cannot act
beneficially unless they achieve adequate concen¬
trations at infected sites within a short time.
A method for examining antibiotic concentrations in
areas of skin inflammation has been developed in
this work. This chapter gives the results of several
studies with antibiotics in skin window exudates
from healthy or leukaemic patients.
THE Shin WIIDOV; HETHOD POH ATTTIBIOTIC STUDIES
The preceding chapter described the technique for
making skin abrasions and for sampling both cells and
exudate /
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exudate fluid. In the following studies antibiotics
were administered* prior to making the skin lesions
and hourly collections of exudate were made for three
hours. Blood for assay was taken at the mid-point
of each hourly exudate collection period so that
some comparison between serum and exudate concentra¬
tions could be made. The method for exudate
collection has already been described (page29method 3,
and figure 2:4)
METHODS ?0H 1TTIBICTIC ASSAY
Some antibiotics or chemotherapeutic agents
can be estimated using chemical techniques but these
methods are not sufficiently sensitive to assay
concentrations below 1 mg/l or small samples.
Moreover, each agent requires different extractions
prior to the chemical assay and this makes comparisons
between different drugs difficult.
The microbiological assay method has been well
tested as a means of antibiotic measurement and has
a flexibility suited to the purpose of this study.
The /
* Oral drugs were given 30 minutes before the skin
trauma, intramuscular drugs 15 minutes before.
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The principle is that a test organism, susceptible
to the drug under study, is incubated in media
containing either standard drug concentrations
or a known dilution of the test fluid. From the
relationship between the organism's growth in the
unknown or the standard mixture , the test concen¬
tration can be estimated. There are two main
methods for microbiological assay (Garrod & 0'Grady,
1968). In the simplest the test is performed in
fluid media containing different dilutions of either
the standard or test solutions. The end point would
be the lowest dilution of either which inhibits growth.
Thereafter the approximate concentration of the
sample can be calculated.
The other method uses solid media which have
been inoculated throughout with suitable bacteria.
Test or standard solutions are applied to these
preparations and the end point is measured as the
diameter of the resultant inhibitory zones following
several hours culture.
There are several advantages of the solid medium
method, particularly that it enables levels which
fall between the standard dilutions to be estimated.
In addition, since contaminating bacteria within the
test/
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test sample can "be distinguished from the assay
organisms, assays are possible in infected fluids
such as sputum. Above all, repeated comparisons
of assay techniques conducted on a national scale
have shown consistently that the plate diffusion
method is more accurate in practice than tube
dilution assays (Reeves & Bywater, 1975).
After several preliminary tests the following
method was found to be satisfactory for the assay
of all the relevant antibiotics.
THE PLATE DIFFUSION ASSAY METHOD
Five hundred mis. of agar medium (A/B medium
no. 2, Oxoid), prepared at a pH suitable for the
chosen antibiotic, were sterilised for 15 minutes
at 120°C and a pressure of 15 pounds per square
inch. The resultant solution was allowed to cool
to 48°C and kept in the molten state at this
X
temperature. The test bacteria were added and the
flasks were carefully agitated. Ten ml. aliquots
were pipetted into 9 cm. diameter Petri dishes and
allowed to cool and solidify on a levelling table.
The antibiotic solutions were either pipetted into
round wells (punched in the seeded medium with a
4 mm/
x For details of the sources of and methods to
maintain the assay bacteria please see appendix 6,
pages 211 & 212-
57.
4 mm diameter suction cork-borer) or applied to
filter paper assay discs (Mast Laboratories Ltd.),
which, were then firmly applied to the agar surface.
By varying the size of the bacterial inoculum,
the lower limit of assay could be altered. If
fewer bacteria were inoculated, the sensitivity was
greater. However, with the lowest numbers of bacteria
it was difficult to measure the resultant zones of
inhibition since individual colonies at the periphery
of the inhibited zone were widely separated. For
those test organisms used, the ideal inoculum for
each 100 ml agar solution lay between 0.05 ml and
0.5 ml of an overnight culture in nutrient broth.
Prior to incubation the plates were left at
room temperature for 2 hours so that pre-diffusion
of antibiotic could take place. All plates were
read after incubation for 13 hours*, by which time
clearly distinguishable bacterial growth was present,
except in the zones around the antibiotic containing
wells (Fig 5:1). Table 5:1 shows the test bacteria
and cultural conditions found to be most suitable for
the antibiotics used in this study. It also shows
the lowest concentration of each drug which could be
measured.
In /
* With Sarcina lutea as test organism around 50
hours incubation is required.
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Figure 3:1
"Typical assay plate to show the degree of growth
and the zones of inhibition produced by ampicillin
added to 4 mm diameter wells. ( Sarcind luted )
Table3:1






















































In the studies of inflammatory exudate from
skin windows, the discs obtained from the exper¬
imental lesions were applied direct to the prepared
assay plates and compared with standards prepared
in pooled normal human serum (P.N.S.) applied via
identical filter paper discs. (Pig "5:2),
Concomitantly, blood samples were taken and the
separated sera were assayed and compared with
appropriate standards.
ANALYSIS 0? ASSAY 55SUITS
Whenever possible, each standard or test solution
was set up in quadruplicate and the mean zone
diameter was calculated from the four individual
results. When the standard concentrations and the
resultant zone sizes were plotted, the curve produced
fitted a polynomial equation of the type:-
y = a + bx + cx (Bennett et al, 1966) where
x is the coded concentration (see * below)
y /
* If X mg/l is the lcwest concentration, coded result is 1
If the concentration is 2 X mg/l the coded result is 2
If " " " 4 X rwr/l " " " " 3
If " " " 8 X mg/l " " n "4
If " " " 16 X mg/l " » " " 5
61.
Figure 3:2 Assay plate showing a large zone of
inhibition around a 12 mm filter
paper disc impregnated with 3.1 mg/l
of clindamycin. (Sarcina lutea)
62.
y is the mean zone diameter at that
concentration and
a, b and c are constants for a given set of
assay conditions (the test concentration
must fall between the highest and lowest
standards)
The equation can be solved for a, b and c
using each set of standards and then a, b, c and
the mean zone diameter (Y) for an unknown sample
can be substituted in the expressioni¬
sm = (b^ - 4nc + 4cY) - b
2c
to give the coded value of the unknown concentration.
Then the unknown concentration (T) is calculated
T = lowest standard concentration x '"nLl^0^^^
This method has been applied by a simple 'on
line' computer programme using BASIC language
(Table 3:2 - programme data, Table 3:3 operational
demonstration of the programme).
The reproducibility of the overall assay
procedure described here using four tests per sample
is within 10?i. However, for the exudate samples
where only one test could be set up each time, the




COMPUTER PROG-RATTLE ?Oa ilTALYSIS 0? ANTIBIOTIC
ASSAYS ( BASIC LANGUAGE)
1 Print "Bioassay "by the Method of Bennett et. al"
2 Print "Enter concentration of strongest standard
solution"
3 Input Z
4 Print"Enter standard diameters smallest first
commas in between"
5 Input Y(l), T(2), Y(3), Y(4), Y(5)
6 Por 1 =1T0 3
7 let T = T + Y(l)
8 Let 3 = S + Y(1)*Y(1)
9 Next 1
10 Let B = (2*Y(5) + Y(4) - Y(2) - 2*Y(l) )/l0
11 Let C = (2*Y(5) - Y(4) -2*Y(3) - Y(2) + 2*Y(l) )/l4
12 Let A = T/5 - 2*0
13 Let 3=S - T-T/5
14 Let V = B*B*10 + C*C*14
15 Let R = (3-7)f2
16 Print "Regression coefficients"
17 Print A, B, C
18 Print "Residual mean square"
19 Print R
20 Print "Enter test diameter"
21 Input D
22 Let X = (3QR (B*B-4*C* (A-D) ) -B)/(2*C)-2
23 Let W = Z*2tX












Assay 16:22 Sysed Tue. 29th Mar. 1976
Bioassay by the Method of Bennett et al
Enter concentration of strongest standard solution
? 48
Enter standard diameters smallest first commas in







Test concentration = 11.9937
Running time: 2.6 sees
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In the case of serum gentamicin assays it has
been possible to compare the accuracy of results
by our method with that of those obtained in other
centres of the United Kingdom. {Reeves & Sywater,
1975). This comparison is summarised in Appendix 2.
RESULTS
1. Antibiotic Concentrations ir Skin Window
Exudates of Normal Subjects
The type of information obtained for each drug
is shown in Pig. 3:3. This gives the serum and
exudate levels of cloxacillin after an oral dose
of 500 mg. Half an hour after the administration
of this antibiotic a skin abrasion was made and the
exudate in the 3 subsequent hours was collected and
assayed. The horizontal dotted lines represent the
exudate level (uncorrected for the difference in
weight in the exudate discs as comnarea with the
XX ■
serum standards). Pigs. 3:4 and 3:5 give comparable
studies with cephalexin and fucidin; in the case of
the fucidin experiment, duplica.te skin windows were
made and the reproducibility of the method was
thereby tested. Table 3:4 gives the mean concen¬





SERUM & EXUDATE LEVELS OF






Figure 3:3 Curves showing the serum and exudate
levels of cloxacillin following an oral




SERUM & EXUDATE LEVELS OF
Figure 3:4 Curves showing the serum and exudate
levels of cephalexin following an oral
dose of 500 mg at 0 hours.
68.
Cone,
m Oj J I.
SERUM AND EXUDATE CONCENTRATIONS
OF FUCIDIN AFTER SOOmg ORALLY
Figure 3:5 Curves showing the serum and exudate
levels of fucidin following an oral dose
of 500 rag at 0 hours.
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from the healthy subjects. Table 3:5 expresses
these exudate levels as a percentage of the
concomitant serum level. The numbers are- too
small to make valid comparisons of the antibiotics.
However, it is interesting that fucidin, which
is 95>° proteinbound, achieved the highest
sustained proportion of the serum level in the
exudate. In contrast cloxacillin, which is also
highly proteinbound, (94/°) attained only 10/& of
the serum concentration in the exudate.
2. Skin Window Studies in Subjects with Chronic
Lyrrnhatic leukaemia
Antibiotic kinetic studies were performed on
5 patients with chronic lymphatic leukaemia using
fucidin as the test drug. Much lower concentrations
were obtained in the exudate from these subjects
than from controls. This effect was even more
pronounced when the exudate concentration was
expressed as a percentage of the concomitant serum
level (Table 3:6). Table 3:7 gives the comparative
data for exudate weight, serum levels and leucocyte
morphology. In the third hour the highest proportion




MEAN CONCENTRATIONS OF SIX ANTIBIOTICS IN
SKIN WINNOW EXUDATES EXPRESSED AS A
PERCENTAGE OF CONCOMITANT SERUM LEVELS X
(Comparison with degree of protein binding)
Hour of Inflammation
Antibiotic 1st Hour 2nd Hour 3rd Hour
Protein
binding
Cephalexin 38 19 20 25$
Clindamycin 34 9 4.9 70 - 90$
Cloxacillin 10 7 7 94$
Pucidin 42 46 28 95$
Tobramycin < 5.5 <6.1 <8.7 25 - 30$
Mecillinam 26 26 28 0 1 tv> O
x Eor dosage see table 3:4
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Table 3:6
SKIN WINDOW EXUDATE LEVELS OF PUCIDIN IN
PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA
(following an oral dose of 500 mg)
Hour of inflammation
Subject Age Sex I II III
1 58 E 0* (0) 11.5* (3.6) 4.7* (11.5)
2 63 P 0 (0) 0.2 (3.5) 1.7 (32)
3 68 P 0.5 (1) 2.15 (2) 3.3 (6.1)
4 49 M 0 (0) 1.4 (4) 0.6 (1.4)
5 59 M 0 (0) 0 (0) 1.4 (19)
MEANS 0.1 (0.1) 1 .0 (2.6) 2.3 (4.9)
S.E.M. 0.1 0.4 0.7
Normal subjects
MEAN 3.7 8.9 5.3
S.E.M. 1.49 1.87 1.62
* mg/l of serum level)
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Table 5:7
WEIGHT OF EXUDATE AND SERUM AND EXUDATE
CONCENTRATIONS FROM SKIN WINDOWS IE 5













































x Please compare with Table 3:6 (page 72) and the
text (page 70)
74
of the leukaemic patients.
3. Correction Factors
Since there is no mathematical technique for
obtaining the correct exudate concentration when
zones which use a variable low weight of exudate
(approximately 5-20 mg) are compared with those
using the greater weight of standard solutions
(35.6 mg - 2.1), correction graphs have been
produced for the antibiotics studied to compare
the effects of different weights of standard.
(Appendix 3). The application of such corrections
to some results from table 3:4 shows that the
acute inflammatory exudates contain higher anti¬
biotic concentrations than that table indicates.




MEAN EXUDATE CONCENTRATIONS OF THREE ANTIBIOTICS
++
IN NORMAL SUBJECTS FOLLOWING CORRECTION FOR
EXUDATE WEIGHT
Hour of Inflammation
Antibiotic n I II III
Cephalexin 4 11(117)* 9-4( 69) 4.3(44)
Clindamycin 4 3.1(130) 1• 2( 43) 0.4(18)
Fucidin 4 14.0(160) 26(134) 18(96)
* All concentrations are given as mg/l. Figures
in brackets are the exudate level as a percentage
of the serum level.
Because the exudate weights were usually much less
than the weights of antibiotic standards the assay
results in Tables 3:4 - 3:7 underestimate the true
exudate concentrations. Table 3:8 indicates the
highest concentrations likely in the exudate. The
antibiotic concentrations studied for anti-staphylococcal
effect in Chapter 5 were based on Table 3:4-
76.
DISCUSSION
Studies in formal Subjects
The concentration of antimicrobial drugs
achieved in an individual tissue is of great relevance
.when that site is infected (Xunin et al, 1973).
During the therapy of infection the' inxerstitial
fluids and the stroma of the various normal tissues,
contain vastly differing concentrations of anti¬
biotics. In contrast the inflammatory response to
infection tends to be similar in all tissues.
Thus studies of antibiotics in acute inflammatory
exudates may provide important information about
the efficacy of an antibiotic in any infected
tissue. The technique described in this chapter
is a new approach to the study of antibiotic kinetics
in man (Raeburn, 1971) and it provides an opportunity
to study host responses to infection (chapters
2 & 4) as well. However, far more normal subjects
must be studied if comparisons between antibiotics
are to be possible.
Recently Tan et al, (1972) have used a skin
window method to examine antibiotic levels in tissue
fluids and have concluded that drugs with a high
degree /
degree of protein binding attain lower concen¬
trations in such fluids than those which are
poorly prot?1/-bound. Their method differs from
my own in an important respect for they cover the
skin lesions with a chamber containing buffered
saline. Thus the antibiotics are studied in an
additional (■unnatural) body compartment. Since
the chamber is filled with non-protein fluid, the
proteins of the inflammatory exudate are greatly
diluted (to about 1/25 of their initial concen¬
tration). Thus one would anticipate that chamber
fluid would equilibrate with the 'free' antibiotic.
Furthermore, the one in 25 dilution must affect
the accuracy of the initial antibiotic assays.
Table 3:9 compares the results with cephalexin
from this thesis (corrected for the weight of
exudate) with those quoted by Tan et al, (1972).
It is clear that the two methods provide different
but complementary information; my method shows the
situation in acute inflammatory exudate, while Tan's
technique may indicate the situation in non-
inflamad tissue fliiids. It is interesting that
another technique for examining interstitial fluid




CEPHALEXIN IN SKIN MINDON EXUDATES
(CONTRASTS BETWEEN TSGHNITUBS)
This thesis
Time after abrasion (corrected Tan et al





Mean peak serum level 13.8mg/l 14.4mg/l
Mean peak exudate
level llmg/l 3.1mg/l
* Exudate levels as aj° of concomitant serum levels.
N.T. = Not tested.
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(in. clogs) provides fluid with a low protein content
and also shows higher concentrations after the less
protein-bound antibiotics. (Chisholm et .al, 1973).
The results here show that if there is a normal
inflammatory response^protein-binding may not have
•an adverse effect. On the contrary some protein-
bound drugs may enter the inflamed site via a
"piggyback phenomenon". However, the contrast
between fucidin and cloxacillin, both highly protein-
bound drugs, indicates that protein-binding alone
(as measured by conventional methods) is not the
only factor which affects inflammatory exudate
levels.
The time at which the highest proportions of
antibiotic reach the exndate' (1st hour of inflammation)
is a time when few leucocytes have been mobilised
(Chapter 2). However, elsewhere we have found that
the exudate of the first few hours is rich in
proteins, particularly IgA and IgM (McClelland et al
1974).* Antibiotic ma.y well be protein-bound but
not necessarily to albumin.
There are other observations which support
the suggestion that protein-binding can sometimes aid
antibiotic distribution. Kattie et al, 1973),
using /
* This study did not separate the first, second and
third hours of inflammation.
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using an in vivo model in mice, showed that naficillin
which is aoout 90% protein-bound in the mouse had
greater therapeutic effect against an experimental
staphylococcal infection than did cloxacillin (80%
protein-bound in mice). These authors took great
.care in controlling their experiments so that the
only difference between the two groups of experiment¬
ally infected animals was the degree of protein-
binding. Ellis et al, (1975) have compared
inflammatory exudate and wound exudate levels of
cefazolin (84% protein-bound) and cephaloridine
(less than 20% protein-bound) using a disc technique
(the inflammatory exudate method was identical to
our own). Both antibiotics achieved high levels
in inflammatory exudate and there was no difference
in the proportion which passed from the serum.
Exudates from surgical wounds contained lower
concentrations of both antibiotics but the highly
protein-bound cefazolin was not at any disadvantage.
It is not yet possible to construct a unifying
hypothesis to explain all the findings with anti¬
biotics in inflammatory exudates. Taken as a
whole they suggest that it is wrong to assume
(as is all too frequent eg Garrod & 01Grady, 1968)
that /
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that high degrees of protein-binding always impair
antibiotic pharmacokinetics.
■Studies with Patients who had Chronic Lymphatic
Leukaemia
This group of patients were investigated
because they had a chronic illness in which
infections requiring antibiotic therapy were
frequent. On the other hand they were all in a
stable clinical state and the minimal trauma
necessary for the exudate studies, seemed justified.
There were no complications following the skin
window abrasions.
The results of these experiments were
surprising since they showed that the C.L.L.
patients absorbed fucidin well and the serum levels
achieved were around twice as high as in normal
subjects, (the patients were considerably lighter
than the healthy subjects). Despite the higher
serum levels, exudate concentrations in the C.L.L.
patients were much lower than in controls. Further¬
more the exudate/serum relationships at each hour
of inflammation were different, so that the course
of acute inflammation in the leukaemia subjects
appeared /
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appeared to be more gradual.
After surveying the literature I have been
unable to find any comparable studies with anti¬
biotics in leukaemic subjects. Their abnormal
immunological responses are well known (particularly
hypogammaglobulinaemia in chronic lymphatic
leukaemia) and these appear to explain the frequent
infections. If the inflammatory response is more
gradual, or is diminished, this might, as indicated
here with fucidin affect the localisation of anti¬
biotics in infected sites.
These studies emphasize the importance of
host factors during the treatment of an infection.
The recovery of a leukaemic patient may not only be
hampered by his poor immunological responses; in
addition there may be secondary effects such as an
interference with antibiotic localisation via the
inflammatory response. Clearly this aspect must
be investigated further in any group of patients
whose immune function is impaired.
83.
SUMMARY 0? CHAPT5R 3
1. Adequate concentrations of several
antiloiotics can be demonstrated in the acute
inflammatory exudate of the skin.
2. During the first hour of inflammation
higher proportions of antibiotic seem to occur in
the exudate when compared with serum levels.
(During this period there are very few exudate
cells).
3. After three hours the antibiotic activity
of normal exudates was lower but cell concentrations
were increasing.
4. In normal subjects no antibiotic so far
studied reached higher proportions in the later
exudates.
5. The ability of an antibiotic to penetrate
into inflammatory exudate is not solely determined
by protein-binding and fucidin, which is 957° protein-
bound achieved the highest exudate levels.
6. Patients who had chronic lymphatic leukaemia
achieved very low fucidin concentrations in the




This Chapter, and the previous one, showed
the concentration of certain antibiotics and of
phagocytic cells in human inflammatory exudates.
The following chapters study in vitro, the anti¬
bacterial effects that such concentrations of
antibiotics or cells might have.
85










METHODS III THIS STUDY:
Separation of phagocytic cells
1. Mixed leucocytes
2. Purified monocytes (plus lymphocytes) 103
Phagocytosis techniques 106
1. Monolayer method
















2. Intracellular killing 112
R3SUITS
A. Normal subjects: 113
i) Phagocytosis and intracellular killing
fcy granulocytes
ii) Phagocytosis by monocytes 117
B. Subjects with a history of repeated infection:
i) Patient with chronic granulomatous 117
disease
ii) Other patients with repeated infection 120
iii) Patients with respiratory infection
due to cystic fibrosis 123
C. Reproducibility of the bactericidal test. 123
DISCUSSION 127
SUMMARY OP CHAPTER 4. 134
87.
THE Ai'TTIHICRQ3IA1 ACTI7IEIB3 0? PHAGOCYTIC CELLS
CHAPTER 4.
"If it were done when 'tis done, then't were
well It were done quickly;"
(Macbeth).
INTRODUCTION
The skin window studies of phagocytic cells
reported in this thesis and by other authors (Rebuck
& Crowley, 1955, Southam & Levine, 1967, Senn et al
1969) emphasize that these cells rapidly accumulate
in inflamed sites. Their subsequent function is
to phagocytose, and later to kill, a wide spectrum
of micro-organisms. The killed organisms are then
digested by the action of a variety of lysosomal
enzymes. Table 4:1 summarizes these anti-microbial
activities of phagocytic cells with a note about the
effector systems and the source of energy (based on
Karnovsky, 1962, Cohn & Hirsh, 1965, Zeya & Spitz-
nagel, 1966, Baehner dc Nathan, 1967, LahST et al
1974 and Stossel, 1974.
To study these phagocytic functions I have used
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micro-organism, Staphylococcus type 42b. This is a
coagulase positive strain maintained in subculture
since 1952 which seems to have low pathogenicity
in the human and which is highly sensitive to
penicillin (minimum inhibitory concentration is
0.006 mg/l.). 'The phagocytic and bactericidal
activities have been examined in this work but digestion
of dead intracellular organisms, not studied here,
is also of great importance.
Phagocytosis
This is a rapid process in either granulocytes
or blood monocytes and their derivatives. Phago¬
cytosis by these "professional phagocytes" is greatly
increased by pre-treatment of the target particles
with serum which contains opsonins. In the case of
the neutrophil polymorphonuclears some complement
factors are also required. Phagocytic activity can
be stimulated by a polypeptide substance, tuftsin,
which is synthesised in the spleen (Constantopoulis
et al 1973). Tuftsin has a direct action on the
phagocytic cells, in contrast to opsonic substances
which act by coating the bacteria thus increasing
their susceptibility to phagocytosis.
Phagocytosis utilises energy derived from anaerobic
metabolism. That it does not depend on aerobic
pathways has been demonstrated by Karnovsky (1962)
and /
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and Baehner & Nathan (1967), who showed that with
or without aerobic conditions lactate is produced
during phagocytosis. Agents which block aerobic
pathways do not reduce phagocytosis but inhibitors
of glycolysis such as fluoride or i&doacetate
produce at least an 80/'o reduction (Cohn 1970).
Synthesis of cell membrane is required for
continued phagocytosis to take place (Verb 1975)
and this is reflected by evidence of increased
phospholipid content. The ability of granulocytes
to synthesise and recycle cell membrane is limited
and there is thus a definite restriction of their
lifespan end of their capacity for phagocytosis.
Monocytes and macrophages derived from blood mono¬
cytes, can synthesise and repair the cell membrane
and they can engage repeatedly in both pinocytosis
and phagocytosis.
The process of phagocytosis is rapid; over
6
90f° of an inoculum containing 5 x 10 staphylococci
per ml can be ingested in 15 minutes by granulo¬





This process is much more difficult to study
and the metabolic processes which accompany it are
complex and controversial. However, there is
general agreement that the final process of a
major killing mechanism is the confrontation of
intracellular bacteria with hydrogen peroxide,
myeloperoxidase and a source of halide which is
usually iodide. The source of hydrogen peroxide
is still uncertain but it requires an increment
of aerobic metabolism via the hexose monophosphate
(H.M.P.) shunt. The enzymes crucial to this
aspect of intracellular killing are listed in
Table 4:2 along with some indication of their main
function, (based on Stossel, 1974, Root at al,
1975, Homan-IIttller, Weening & Roos, 1975).
Briefly, the energy released from the pentose
pathway is utilised via a hydrogen transport
system (either HAD/HAD^, HADP/1IADPH2 or both)
to produce superoxide (C^-) from oxygen under the
influence of oxidase enzymes. Superoxide is
itself bactericidal or it reacts with hydrogen
peroxide (HpC^) to form hydroxyl radicals (and




Intracellular enzymes and bacterial killing


























Superoxide dismutase Converts 09 - to
H2°2
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Superoxide in aqueous solution can generate
spontaneously and the mixture of these two
peroxides is bactericidal for some strains of
staphylococci (Babior, Curnutte at Kipnes, 1975).
The hydrogen peroxide generated is available for
the myeloperoxidase - mediated bactericidal
system. There is much to be learnt about these
linked bactericidal systems, particularly about
their specificity against different organisms.
Chronic granulomatous disease (C.G.D.) is
the prototype of disorders of intracellular
killing but there is some controversy as to the
defect. Some have shown a reduction of 1TADH
oxidase activity to less than 25f° of normal
values (Baehner & Karnovsky 1963), while others
have not (Holmes & Good 1972). Recent studies
have shown that in C.G.D., the levels of super¬
oxide in phagocytosing granulocytes are grossly
reduced compared to normals. This still does not
identify the primary biochemical lesion but it
has been found to be the most promising test,
so far available, for recognising female carriers




Quite separate from these controversies
which concern mechanisms for generating EUC^,
there is good evidence that other "bactericidal
systems exist in phagocytic cells. These are
also listed in Table 4:1. Evidently each phago¬
cytic cell has reserve mechanisms available that
could compensate for inefficient activity of
other pathways.
Intracellular Digestion
Dead bacteria must be removed and this
function is served by the group of lysosomal
enzymes. Lysosomes, heterogenous as regards both
their size and biochemical actions, are easily
visible on electron microscopy or with high power
light microscopy. Table 4:3 lists some enzymes
contained in lysosomes witn a note on their
subcellular origin., pH optima and likely digestive
function, (from Sainton, 1972 & Barrett, 1972).
It is relevant that in those genetic diseases in
which lysosomal enzymes are known to be deficient,
there is seldom the clinical problem of infection
(Harkness, 1972). This above all, separates the
digestive activities of phagocytic cells from
those which accomplish killing.
TableA-:3
SOMEENZYM SFPRI ARYA DSECONDARYLY30S0MBS
T?r
mzyme
Lysozyme(muramidase) Lipases Gathepsins(A-E) Otheracidhydrolases egi)B-glucuronidase ii^-L-fucosldase RNAse Collagenases Myeloperoxidase Alkalinephosnhatase
OptimumpH 6.2 4.2-.5 2.5-6 4.3 5.6-6 1 5.4-6 7 4.0 7.4 7.6-9.9
Cellsite
lrylysosomes[j2ndary" lrylysosoraes lrylysosomes lryysosomes& endoplasmic reticulum lryysosomes lrylysosomes lryysosomes lr.yysosomes 2ndary"
Action
Hydrolysespartfbact¬ erialcelwalls Hydrolyseglycerylest rs oftriglycerides& phospholipids Degradeproteins& polypeptides Removester inalresidues fromligosaccharides& glucuronides Degradesoligosaccharides DepolymerizesR.N.A. Degrades&solubilizes collagen Removes Unknown
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AS5B3SH3I7T OF PEAdOCYTIC FUIICTI0H5
Phagocytosis
A basic technique for the measurement of phago¬
cytosis is to incubate the cells and bacteria
together in a culture medium containing serum and
to prepare slides so that the intracellular bacteria
may be counted (van Furth & van Zwet 1973), (Pigs.
4:1 and 4:2). The information obtained is the
proportion of cells which are capable of phagocytosis
and the mean number of intracellular organisms per
phagocytic cell. This method gives no information
about the kinetics of phagocytosis or about intra¬
cellular killing. However, the assessment of
phagocytosis in purified cell preparations, such
as monolayers of monocytes on glass, is a useful
marker as to cell type (van Purth et al 1972).
Rate of Phagocytosis
Further information such as the speed of
phagocytosis can be obtained by sampling a suspension
of cells, bacteria and serum during incubation at
37°C. After spinning the aliquots at lOOg for 4
min , (to sediment the leucocytes while leaving
extracellular bacteria in the supernatant), viable
counts /
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Figure 4:1 High power view to show intracellular
staphylococci after ingestion by a
neutrophil.
(G-iemsa stain x 1000)
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Figure 4:2 High power view to show intracellular
staphylococci after ingestion "by a
monocyte.
(Giemsa stain x 1000)
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counts are performed on the supernatant by a pour-
plate method (Maaloe 1946). Such studies have shown
that normal human granulocytes can phagocytose
roughly 91$ St.aphylococcus aureus in 15 minutes
(van Furth & van Zwet 1973) or 90/= Pseudomonas
pyocyanea in one hour (Young & Armstrong 1972),
but only in the presence of serum.
Intracellular Killing
There is considerable variation in techniques
to measure intracellular killing. The most exacting
method is described in detail by van Furth & van
Zwet (1973)# Briefly, the phagocytic cells
n
(l x 10 per ml) are mixed with an (estimated)
equal number of the test bacteria plus 10$ human
AB serum. After a sufficient period of incubation
to allow phagocytosis (usually 15 mins) the
preparation is spun slowly (lOOg) thus sedimenting
the leucocytes and intracellular bacteria. The cell
layer is carefully wasned and then re-incubated in
fresh medium for 2 hours while sub-sampling regularly.
Bach sub-sample is diluted (l in 2) and the ceils are
sedimented and then lysed with distilled water.
After careful agitation the viable bacteria released
are counted by a standard pourplate method. Changes
in /
101
in the number of viable intracellular bacteria
during incubation, probably represent the killing
ability of the phagocytic cell studied. However,
an avoidable limitation is the tendency of many
bacteria to form clumps so that in the counts
10 organisms or so may only form one colony.
Simpler methods are based on the fall in total
bacteria, (extra and intracellular) in a phagocyte/
serum suspension (Biggar et al 1971). Some authors
rely on the use of antibiotics, added to the medium
after a period of phagocytosis to kill extracellular
organisms, (eg. Alexander et al 1968). A variant
of this principle utilises lysostaphin an antistaphy
lococcal enzyme which, while remaining extracellular
rapidly destroj^s most strains of staphylococci
(Baughn & Bonventre, 1975). Solberg (1972) has
developed a further method in which the intraceliula
killing of some aliquots is inhibited in vitro by
phenylbutazone, thus making possible an estimation
of the killing which occurs in the earliest minutes
of incubation. In other methods the initial killing
process is obscured by phagocytosis.
A new method which has promise as a screening
test uses a completely different principle. Neutro¬
phils (or other phagocytic cells) are incubated with
bacteria /
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bacteria while adherent to glass as a monolayer.
After phagocytosis has occurred the preparations
are washed and incubated with H - thymidine.
This will label the viable bacteria which can be
demonstrated by autoradiography. Since dead bacteria
will not label, an estimate of intracellular killing
is possible. Cline (1973) who developed this technique
has claimed that it distinguishes clearly between
patients with chronic granulomatous disease and
controls. It is not applicable to studies with
many species of bacteria such as Escherichia soli. In
addition many workers in this field have been unable
to repeat Cline's results (van Purth - personal
communication).
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METHODS IN THIS STUDY
Separation of Phagocytic Cells
1. Mixed leucocytes (used in studies of granulocyte
function)
Mixed leucocytes were prepared from heparinised
venous blood by dextran sedimentation. Three ml.
5$ dextran (M.W. 250,000 - Pharmacia, Uppsala,
Sweden) in normal saline were added to 10 ml. blood
containing 100 units heparin (without preservatives)
and mixed gently before incubation for j>v minutes at
37°C (at a slope of 45°). The supernatant containing
leucocytes was then removed and spun at 100 g for 10
minutes. The plasma/dextran supernatant was discarded
and the cell button was then washed twice using heparin¬
ised physiological saline. The cells were then
suspended in Hank's solution (Appendix 4) to a
7
final concentration of 1 x 10 phagocytic cells*
per ml.
2. Purified monocytes (plus lymphocytes)
These were obtained relatively free from
contamination by granulocytes by a method similar
to Boyum (1968). Twenty ml. of 45$ ficol (Pharmacia,
Uppsala, /
* counted in a Neubauer chamber
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Uppsala, Sweden) in double distilled water was mixed
with five ml. of 397" hypaque, (Nyegard, Oslo, Norway).
The mixture was sterilised by filtration through a
0.4 u filter (Millipore UK ltd.) and 4 ml. aliquots
were placed in sterile falcon tubes (15 x 90 mm).
Eight ml. portions of mixed whole blood (containing
heparin 10 units/ml.) were carefully layered over the
ficol/hypaque columns. After centrifugation at 420 g*
for 20 minutes the tubes showed four distinct columns
(Fig 4:3). The top layer (plasma plus platelets)
was discarded, the second layer contained monocytes
and lymphoid cells and the third layer was mainly
ficol/hypaque mixture. The granulocytes and clumped
erythrocytes formed the bottom layer. For these
experiments the second (monocyte) layer was taken,
mixed with an equal volume of physiological saline
plus 0.001 Molar EDTA and recentrifuged at 100 g.
The sedimented cells were washed three more times
with saline/EDTA and resuspended in medium 199 to
the required cell density.1
* 1800rpm for 'Christ' bench centrifuge and 14 cm.
radius for swingout head.
** The proportion of monocytes in this suspension












Figure 4:3 Tube showing 4 layers from which
monocytes and lymphocytes (second
layer) can he separated.
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Phagocytosis Techniques
1. Cell monolayers on glass coverslips within
Leighton tubes containing 5$ CO2 were incubated at
37°C for an hour with medium 199 containing 10$ AB
7
serum and 2x10 staphylococci per ml. They were
then washed six times with warm medium, rapidly air
dried and mounted face uppermost prior to staining.
After giemsa staining the proportion of cells which
were phagocytic and the average number of bacteria
per cell could be assessed (Pigs. 4:1 & 4:2). This
gave only qualitative information.
2. The kinetics of phagocytosis was studied
by taking phagocytic cells in a concentration of
7 7
1 x 10 /ml. and mixing with an estimated 1 x 10 /ml.
of staphylococci (type 42b). AB serum was added to
a final concentration of 10$. After a control
sample had been taken the mixture was incubated
(with rotation at 16 rpm) for either 15 or 30
minutes at 37°C. It was then centrifuged at 100 g
for 5 minutes, the supernatant was taken for
viable counting and the cell button was used for
measurement of intracellular killing (see below)
or the preparation of smears for microscopy. The
unincubated sample was also spun at 100 g and the
supernatant/
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supernatant was collected. These supernatants
were each diluted to 10~ 10~ ^ and 10"" ^
in saline. Aliquots of 0.1 ml. were then spread
on nutrient agar^in 9 cm. Petri dishes using bent
glass rods. These rods were sterilised between
plates by rinsing in methylated spirits and flaming.
After overnight incubation at 37°C the number of
colonies on each plate was counted using an electric
counter which recorded each individual colony when
it was touched by a metal probe. Counts of less
than ten, or more than 500, colonies per plate were
not analysed. The viable count of bacteria in the
original supernatant was calculated by finding the
mean of duplicate results for each sample after
correction for dilution factors. Pigs 4:4 and 4:5
summarise the methods used in the quantitative
assessment of phagocytosis.
Intracellular Killing
leucocytes and bacteria were prepared and cultured
with AB serum as for phagocytosis testingxx After either
15 or 30 minutes incubation (with rotation) the
complete mixture was spun at 100 g for 4 minutes and
the supernatant was removed. The cell button was
washed twice with heparinised physiological saline
and/
x for details please see appendix 4, page 189.
xx The final volume of the cell/bacteria suspension
















Figure 4:4 Method for separation of leucocytes
for studies of phagocytosis and intra'
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Figure 4:5 Basic technique for measurements of
phagocytosis ("by counting supernatant
bacteria) or intracellular killing
(by counting leucocyte associated
bacteria).
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and then suspended in Hank's solution plus 10°/o AB
serum to the original volume. This mixture was
incubated for a further 2 hours with sub-sampling
at 0, 30, 60, 90 and 120 minutes. Each 0.4ml sub-
sample was mixed with an equal volume of ice-cold
Hank's solution, spun at lOOg for 4minutes and the
supernatant was discarded. The cell button was
mixed with sterile distilled water (containing 0.01?£
bovine serum albumin) and vigorously mixed by
pipetting, to lyse the phagocytic cells, thus
releasing all bacteria which were still viable.
These preparations were diluted in tenfold steps to
10 " 4 and spread on plates for viable counting as
detailed on page 107. For most experiments there
was a control tube containing bacteria, Hank's
solution and 10?£ AB serum, from which the rate of
bacterial growth could be estimated.
STATISTICAL ANALYSIS
1. Phagocytosis (see fig. 4:6)
From the initial extracellular bacterial count
(x) and the extracellular count after 30 minutes
incubation (y), the phagocytic index at 30 minutes




























Figure 4:6 Phagocytosis and intracellular hilling
by neutrophils from a healthy male
subject with the calculated T|-
(phagocytosis) and the bactericidal
index.
x
m i r> s
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Ph3Q = logQx - logey ( i)
Thereafter the half time for phagocytosis (T-g-) could
"be computed:-
li = x 30 (ii)
Thus if the initial extracellular "bacterial count was
6 5
5 x 10 and at 30 minutes it was 1 x 10 then
Ph^Q = loge 5 x 106 - loge 1 x 105
15.4 - 13.8 = ( i)
and the half time for phagocytosis (T-g-)
= x 30 =13.0 minutes (ii)
2. Intracellular Hilling
A typical time course for normal intracellular
killing is given in Pig 4:6, which records the number
of viable bacteria (n) against time on a semi-logarithmic
scale. Since logarithmic transformation produces a
near linear relationship with the time of incubation
(t), the relationship can be expressed as log n = a + bt.
Where b is the slope of the relationship and a is the
intercept on the y axis, which represents the natural
logarithm of the 'idealised1 initial count of bacteria.
Por comparisons between different individuals, the rate
of killing is indicated by the slope 'b'. Por
convenience /
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convenience a bactericidal index (B) has been derived
from b:-
Bactericidal index (B) = -b x 1,000 (rounded off to
1 decimal place)
This index is high when there is rapid intracellular
killing and very low (often less than 1.0) if killing
is reduced.
Thus if the number of intracellular bacteria at
0, 30, 60, 90 and 120 minutes was 4 x 10^, 1 x 10°,
5 6 S6x10 , 4.5 x 10 and 2 x 10 respectively then a
would be 14.85 and b would be - 0.02267.
The bactericidal index (B) = 22.7, which is at
the upper end of the normal range.
When a and b are computed it is easy to calculate
the coefficient of correlation (r) for the set of
figures and this represents the scatter of individual
resultsx from the straight line relationship.
RESULTS
A. Normal Subjects
(i) Phagocytosis & intracellular killing by
granulocytes
In the male individual whose results are shown
in Pig 4:6 the value for T-g- (phagocytosis, 30 minutes)
was/
x
Differences between the mean results of the T-g- or
bactericidal index of the groups studied were tested
using the * t * distribution (Armitage P., (1971)
Statistical Methods in Medical Research, Blackwell,
Oxford)
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was-5.15 minutes and the bactericidal index was
5.3. Table 4:4 shows the individual results in
10 healthy "females and 10 healthy males. When
both sexes are combined the mean Ty was 5.56 min.
(+ 1.58 = S.D.) and there was no significant
difference between the two sexes, 5.67 - 1.72
for females and 5.47 - 2.22 for males. The mean
bactericidal index in 10 females (aged 20 - 70)
was 12.73 - 5.18 and for 10 males (aged 21 - 31)
was 7.21 i 3.05. This represents a significant
difference between the two sexes (p<0.01 using
the t distribution). There was no correlation
between the Ty (Phagocytosis) and the bactericidal
index in 17 subjects tested by both methods
(r = — 0.2804). The mean age of tnese healthy
controls was 34 years, but the females were older
than the males. There was no suggestion in either
sex that the bactericidal index varied with age.
A small number of experiments were carried out
after a 15 minute period for phagocytosis instead
of 30 minutes. These results are shown in table
4:5 and indicate a slight decrease in the Ty for
phagocytosis but an increase in the bactericidal




BGCYTOSIS \ND INTHACELLOLAfi^KILLIBS OP
^ ; ' — ——
«aicafecoog8 •«»' wffimtoCTtea raow :oa-.u .a->j .r.o
Test Ty (phago¬ Bacteri-
Code ;-0 Sex cytosis ) cidal index
2 23 F 4.65* 15.4" ■
3 42 F 3.9 13.4
6 56 F 4.95 10.0
7 58 F 8.64 11.2
10 54 F 6.03 Mean 6.0 Mean
11 70 F IT.D. > = 5.67 16.8 > =12.73
26 26 F 4.1 S.D=1.72 23.2 3.D=5.18
74 22 F 7.79 14.8
36 36 F 5.3 6.2
20 20 F N.D._ 10.3
16 22 MPi 6.71*" 8.5~
28 27 M 5.85 12.3
38 28 M II.D. 5.1
40 21 "jyr 5.38 4.9
50 22 M 3.15 Mean 10.1 Mean
54 30 M 5.15 > = 5.47 5.3 >= 7.21
69 30 H 4.99 3.0=2.22 6.0 3.D=3.05
102 31 M 7.26 7.2
106 23 M 7.40 2.4
116 22 M 3.35 10.3
Both sexes Mean Ty = 5.56
S.D. 1.58
* Phagocytic stage = 30 minutes
IID - ITot measured.
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Table 4:5
PHAGOCYTOSIS* AMD INTRACELLULAR KILLING
IN NINE HEALTHY SUBJECTS
Test Bactericidal
code Age Sex Ti index
E.L. 26 F N.D. 40.0
P.D. 18 F 2.44 14.8
M.M. 43 F 4.14 15.0
L.P. 21 F 3.28 16.6
MEANS 3.29 21.60
S.E.M. 0.49 6.15
J•A.R. 34 M 3.22 17.5
A.S. 28 M N.D. 6.2
P.P. 24 M N.D. 19.0
D.V. 31 M N.D. 12.4
E.H. 6 M 4.23 1 5.7
MEANS 3.73 14.16
S.E.M. 2.27
* Phagocytic stage = 15 minutes
Please compare with table 4:4
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ingestion the killing is more rapid than subsequently
and that during a 30 minute period for phagocytosis
some significant intracellular killing takes place.
Each of the paediatric patients in the infected
group or the cystic fibrosis group could not be
matched with a healthy child of the same age. Table
4:6 gives the results in 6 healthy children aged 2
to 10. There was no gross difference between this
small group and the healthy adults, but a difference
between the sexes was not found.
(ii) Phagocytosis by monocytes
Results of five experiments using the
monocyte preparations are shown on table 4:7 which
compares the Tycalculated from the extracellular
bacteria at either 30 minutes or 60 minutes. The
Ty is considerably longer than that for granulocytes
indicating a slower rate of phagocytosis by the
monocytes.
B. Subjects with a History of Repeated Infection
(i) Patient with chronic granulomatous disease.
At the time of this study the patient R. McG. was
age 6 and had a history of repeated infections since




GRANULOCYTE FUNCTION IN NORMAL CHILDREN
Bactericidal
Patient Sex Age Ti index
1 M 2 4.14 7.2 N
2 F 4 6.18 2.4
3 M 4 6.02 10.0
4 M 6 9.03 8.1
5 F 8 5.32 6.3




















M1 1.3 X 106 4.8 x 105 14.11 17.90
M2 4.9 X 106 7.6 x 105 39.67 40.19
M3 4.4 X 1 O6 4.0 x 105 18.50 13.41
M4 5.6 X 106 5.3 x 105 19.26 21.9









* Monocytes obtained by method 2 (page 103) were
mixed with Staphylococcus albus and 10$ AB serum
in Hank's/gelatine. Ty was calculated as on
page 110 using the 0 min. count and either the
bacterial count at 30 minutes (T-§- (30)) or at
60 (TJr (60)).
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glands and the abdomen and the histological features
were of a granulomatous reaction. The child had
received an 18 month course of antituberculous
therapy without benefit. A male sibling had died at
six months because of acute bronchopulmonary infection,
and the mother had biochemical evidence (quantitative
U.B.T. test, Dr. A.D. Sain) that she was a carrier.
Three studies of phagocytosis and killing in this
boy, his mother and his sister are summarised in
Table 4:8 which shows the T-j- (Phagocytosis) and
bactericidal indices both before and after various
treatments.
(ii) Other patients with repeated infection
These patients all had a history of chronic
infection persisting for at least 6 months. The site
of the infection and further details including the
phagocytic and bactericidal indices are given in Table
4:9. Comparison of the group of infected females
and the normal females shows a significant difference
(p<0.0l) in that the infected individuals had
reduced bactericidal indices. There was also a
significant difference between the infected males
and controls but only at the 5?° level. The mean
bactericidal index for infected females did not




GRANULOCYTE FUNCTION IN CHROMIC GRAMJLOMATOUS DISEASE
(Conditions & methods as in Table 4:4)
(see family tree appendix 5, page 190)
A. RESULT S IN RMcG. ased 6
BACT.
TEST TREATMENT Ti INDEX
1 Nil 8.73 0
2 Co-trimoxazole 8.54 0
3 Clofazamine* (in vitro) 15.1 0
4 Clofazamine**(in vivo) 10.75 3.1
MOTHER OP RMcG
1 Nil 3.9 13.4
2 Nil 3.68 15.0
SISTER OP RMcG
1 Nil 3.36 4.5
2 Nil 4.14 3.9
* 1 mg/l final concentration
** 100 mg daily orally for 3 weeks
Table4:9 Patient code














































































The infected patients showed no significant difference
from controls as regards the T-g- phagocytosis.
(iii) Patients with Respiratory Infection due
to Cystic Fibrosis
Clinical details of these subjects are given in
Table 4:10. The mean bactericidal indices of both
the male and female groups is also different from
the appropriate normals but this is only significantly
different at the 5% level. The cystic fibrosis
patients do not significantly differ from the infected
patients in either phagocytosis or bactericidal indices.
C. Reproducibility of bactericidal test in normals
and in disease
Since many in vitro conditions can alter the
intracellular -killing one would expect considerable
J
variation in results from one day to another. Three
control patients, two infected patients, two carriers
of chronic granulomatous disease (C.G-.D.) and two
patients with cystic fibrosis had the test repeated
after an interval of at least one week. The results
are shown in Table 4:11 which lists the two results



































RESULTS 0.P -REPSAT BACTERICIDAL T!EST3 IN 7 SUBJECTS
Bactericidal
index
Codes Sex Age Condition 1st test 2nd test
29/45 P 23 Cystic fibrosis 5.93 5.42
53/113 P 16 H ft 6.01 7.6
24/25 M 18 Skin infection 5.0 CD
58/81 ? 61 Pelvic infection 2.2 2.2





P 19 Probable carrier
of C.G.D.
4.5 3.9
2/74 P 23 Healthy 14.8 15.4
16/50 M 22 H 10.1 3.5





The measurement of bacterial killing within
polymorphonuclear leucocytes is clearly liable to
many technical errors but the reproducibility in
these initial tests is acceptable.
An important aspect of these in vitro studies
•with staphylococci and granulocytes is the necessity
for careful control studies. Thus in initial studies
I found that, in the presence of 10^ AB serum, but
without leucocytes, the staphylococci could multiply about
eight-fold within 2 hours. Likewise it was shown
that if rotation was omitted there was negligible
phatocytosis after 30 minutes. The importance of
these and of other factors (such as the bactericidal
action of Hank's solution if gela.tine or bovine serum
albumin are not added), have.been stressed by several
authors (Cohn and Horse, 1959, Habinovitch, 1968,
van Furth & van 2wet, 1973).
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DISCUSSION
Phagocytic cells play a major part in the
response to invading micro-erganisms and in the
past ten years there have "been a spate of papers
which describe methods for testing granulocyte and
monocyte function (see van Furth and van Zwet 1973).
It is usually impossible to compare the results of
different techniques quantitatively but a body of
information has been built up about the qualitative
phagocytic cell defects which occur in a wide range
of conditions (eg Raeburn 1975). In any situation
the rate of phagocytosis and of intracellular killing
will differ for each organism tested. In many
patients these rates will also show considerable
fluctuation from day to day.
The method for assessing phagocytosis and intra¬
cellular killing used in this study was very nearly
the same as methods described by three other authors.
(Li, Mudd & Kapral 1963, Johnston & Baehner 1970,
van Furth & van Zwet 1973). In particular, all
used strains of Staphylococcus aureus in an initial
concentration between 5 and 10 x 10^ organisms per
ml. From their figures one can calculate the T-y
phagocytosis and bactericidal indices and these
are /
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are compared in Table 4:12. The comparisons, although
incomplete because the other authors only quoted mean
results or one "typical" experiment, show that our
measurements of phagocytosis gave broadly similar
findings.* The rate of intracellular killing measured
in this work "was less than that found by the other
authors. The difference between our results and
those of Professor van Furth stem in large part from
the longer period of phagocytosis (30 minutes) used
here. Although this allowed a greater amount of
ingestion, it meant that the early, most rapid phase
of intracellular killing was obscured. Thus the
experiments using a 15 minute period for phagocytosis
gave much closer results to those obtained in Leiden.
(See table 4:5)
To the best of my knowledge a difference between
the intracellular killing of females and of males
has not previously been demonstrated. Few authors
have stated the sex of their healthy control subjects
and when the sex was recorded individual results
are not quoted. Our male and female subjects are
not identical in all other respects so this observation
requires further substantiation. Nevertheless, the
results are in keeping with clinical evidence that
males /
* The shorter T-y in my own studies has not been adequat¬
ely explained but it could be attributable to




C0:rPA5I50TT 0? Tt & BACTERICIDAL I1TDIC5S USING
HUMA1T GBAHULOCYTES & STAPHYLOCOCCUS AUREUS
Study Tt (mins)
Li et al., 1963 8.23 •
Johnston & Baehner, 1970 Hot done



















* Phagocytic stage = 15 minutes
** Phagocytic stage = 30 minutes.
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males suffer more infections than females and with
reports that concentrations of immunoglobulin M
are one third higher in females than in males
(Grundbacher, 1972). For the present it is prudent
to ensure that control subjects are sex-matched in
addition to ether matching, especially when testing
for carriers of chronic granulomatous disease.
The studies with human monocytes show that
these cells phagocytose Staphylococcus a 1 bus at a
slower rate than do neutrophils (Table 4:7). This
confirms a recent report which showed that the phago¬
cytic defect occurred with Salmonella, 5. Ooli and
Listeria as well as Staphylococcus aureus (Steigbigel
et al, 1974). These authors also show that intra¬
cellular killing of staphylococci by both neutrophils
and monocytes is similar, having corrected for the
differences in phagocytosis.
It is well established that tests of intracellular
killing can detect the defect present in chronic
granulomatous disease. The method of analysis used
here helps to quantify the defects and in a proven
case repealed tests showed a consistently low
bactericidal index. We studied the effect of clofazamine,




neutrophil functions and showed a slight reduction
of phagocytosis and a minimal improvement of intra¬
cellular killing. (Table 4:3). If we analyse the
data of Johnston & Baehner (1970) using the same
mathematical techniques, the addition of glucose
oxidase coated on to latex particles improved the
bactericidal index in one C.G-.D. patient from 4.8
to 11.4. Table 4:8 also illustrates a pitfall in
the investigation of this disease, for the patient's
mother, who is an obligate carrier (see pedigree,
appendix 5 ), had normal bactericidal indices on
two occasions. In contrast the patient's sister
had bactericidal indices which are quite compatible
with her being a carrier.
These experiments (Tables 4:4 and 4:9) show
that the bactericidal index in a group of patients
suffering from a range of infections, in different
sites, is significantly lower than in healthy controls.
This finding has also been reported by Solberg &
Helium. (1972), who showed that the bactericidal
defects were probably the result of infection .and
were associated with prominent cytoplasmic vacuolisation.
The low bactericidal indices in cystic fibrosis
patients (Table 4:10) in whom the immediate cause
of infection is stasis in the respiratory tract, also
point /
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point to infection as the main causative factor
in the neutrophil dysfunction. The cause of this
phenomenon is not yet certain "but the "bactericidal
defects may be the result of known metabolic
alterations in the "toxic"neutrophils. (McCall et
al, 1973). How these occur is also obscure; since
neutrophils do not recirculate after reaching a
site of infection,the triggering factors must be
in the serum.
In experiments with dogs who had induced, cell¬
ulitis and abscesses Alexander and his colleagues
could not show a neutrophil defect even though 5
out of 6 of their patients with surgical infections
had mild to moderate decreases in the rate of intra¬
cellular killing. (Alexander, Hegg & Altemeier,
1963). In the human the transient neutrophil dys¬
function may well play a part in perpetuating a
chronic infection. In addition the findings show that
if a patient suspected of having C.G-.h. is to be
properly tested an infected patient should be
included as an additional control.
There are many technical difficulties inherent
in bactericidal tests as described here and far
greater experience in healthy subjects is required.
It /
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It is better to take aliquots frequently during the
intracellular killing phase and the five sampling
periods up to 120 minutes used here should perhaps
be a minimum. By using the slope of the regression
of the natural logarithm of the bacterial count
* .against time as a basis for comparisons, Ameaningful
average based on the 5 sub-samples is obtained.
This will minimise the error produced by variations
in bacterial courts in individual samples. Por this
reason the method has advantages over other statistical
techniques which rely on measurements at only 2 time
periods (eg Hoffman & Bullock, 1973). Despite these
improved techniques, the range of results in normal
subjects is wide and it is difficult to interpret a
slightly low bactericidal index in an individual
patient. The grouped data is of much more significance
and by further consecutive studies of patients during
an infection and its treatment it may be possible to




A method for testing the action of separated
neutrophils or monocytes against a laboratory strain
of Staphylococcus aureus in vitro has been exploited
in both normal and infected subjects. A concentration
of neutrophils which can be achieved in inflammatory
sites in vivo (see chapter 2) can ingest a similar
number of staphylococci and the mean half-time of
this reaction is 5.56 mins (+ 1.53.= 3.D.). In
contrast the half-time for phagocytosis by normal
monocytes is 24.01 mins {- 10.21). Intracellular
killing by neutrophils is slower than phagocytosis
and the half-times measured here in normal subjects
range from 29 minutes to 2S0 minutes, (the intra¬
cellular killing studies have been compared using
a 'bactericidal index' to avoid any confusion with
the rate of phagocytosis. This index is mathematically
related to the half-time). Compared with other
similar studies these results show rather slower
intracellular killing and in part this is because
my method concentrates on the "residual killing
capacity" which does not take account of any intra¬
cellular killing in the first 30 minutes after the
start of phagocytosis. Normal females appear to
have /
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have more rapid intracellular killing than do normal
males and this requires further study.
Patients with chronic infections, as a group,
have a reduction in intracellular killing capacity
without any change in phagocytic rate and this also
occurs in patients with respiratory infection due to
cystic fibrosis. These findings may well be of
clinical significance but at the least they indicate
some difficulties in interpreting tests of neutrophil
function in individual patients. A simple method for
analysing similar studies has been discussed and it
makes possible a semi-quantitative comparison between
different reports.
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THE AITTIMIGaOBIAL ACTIVITIES 0? AETI3I0TIG3
IN VITRO AI--7D IIT VIVO
CHAPTER 5
"I do not know what our soldiers do to the
enemy, but, my God, they frighten me"
(Wellington, 1814).
INTRODUCTION
The approach to this thesis was based on an
assumption; this was that the efficacy of an anti¬
biotic treatment could not be assessed fully,
unless the important host responses to infection
were recognised and measured. If an individual
infection is caused by a specific number of
bacteria, recovery will occur when these organisms
have been destroyed partly by antibiotics and
partly by the host defenses. When two antibiotics
are compared, the host defences in each treatment
group should be similar if differences in the
outcome are ascribed to the therapy, large scale
antibiotic trials would tend to reduce major
differences in host defences between treatment
groups and identify the antibiotic with the highest
overall /
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overall efficacy. However, individual patients
may sometimes benefit from treatment with anti¬
biotics which have not been exceptional in large
clinical trials.
Prom the data in Chapter 2 we can calculate
the rate at which the phagocytic cells accumulate
in an inflamed site and their approximate concentration.
In Chapter 4 the action of phagocytic cells against
a single organism, Staphylococcus type 42b, was
assayed. In the following studies several anti¬
biotics in concentrations which occur in inflammatory
exudate (Chapter 3) were tested against the same
staphylococcus in a similar in vitro system.
1. BACTERIAL KILLIPG 3Y ANTIBIOTICS IN VITRO
METHODS;
Each drug was prepared in Hank's solution +
0.1# gelatin and then mixed with a suspension of
7
approximately 1 x 10 staphylococci per ml and
with 10# AB serum. The final antibiotic concentrations
were as detailed in Table 5si. The mixtures were
incubated at 37°C for 4 hours and aliquots were




KILLING- 0? STAPHYLOCOCCUS 42b 3Y FIVE ANTIBIOTICS
(Comparison with T-g- phagocytosis)
x xx
Concentration M.I.C.
Antibiotic (mg/l) T'Jr A/B (ms/l
120
Clindamycin 5 187 0.8
Cloxacillin 5 72 0.2
Cephalexin 5 60 0.03
Pucidin 20 >300 0.5




(30 mins) (Prom table 4:4) 5.6 5.9
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samples were immediately mixed with an equal volume
of ice-cold Hank's solution, and were diluted in
tenfold steps prior to plating (see page 107). From
the resultant counts of viable bacteria, the rate of
antibiotic killing could be assessed:-
, . log 2 t *
Ti A/B = X X
log nQ - log nt
Alternatively an antibiotic killing index could
be calculated: -
log n - log n, 100Q *A/B index = 2 x 'uuu
t
(for both equations nQ = initial count of bacteria
and n_j. = count at time t).
RESULTS
Figure 5:1 shows the decrease of viable bacteria
in the presence of clindamycin (1 mg/l.) during 4 hours
of incubation. Similar curves occurred with cloxa-
cillin and cephalexin, except that with these two
antibiotics there was an initial increase in bacterial
count at 30 minutes before subsequent killing.
Fucidin/
* The T-g- A/B and the A/B index provide measures, of
the rate of antibiotic action which can be directly




Figure 5:1 Effect of clindamycin (lmy/1. final
concentration) upon the number of
viable staphylococci in medium + 10$
AB serum but without leucocytes.
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Fucidin in a concentration of 20 mg/l scarcely-
reduced the number of viable bacteria (Ty>300 mins).
£9
In the absence of antibiotic ({Fig oil) there was
approximately a 12 fold increase in bacteria during
4 hours incubation in this culture system. The
mean T{- A/B for each drug studied is shown in Table
5:1 which also records the minimum inhibitory
/ \ X
concentrations (M.I.C.) of each drug measured in
nutrient broth by a standard method. (Cruickshank,
1975). The foot note to this table shows the
pooled results for Ty phagocytosis in normal and
infected subjects as detailed in Chapter 4. Table
5:2 shows the antibiotic killing indices calculated
for each drug with a footnote showing the bacter¬
icidal indices already described in Chapter 4.
DISCUSSION
In this cell-free culture system, staphylococcus
is slowly killed by some antibiotics but only-
after an initial delay. Fucidin inhibits growth
of the organism but after four hours there was a
minimal killing effect. Comparison of the half-
times for antibiotic killing of the organism with
the half-time for phagocytosis by neutrophils shows
that phagocytosis occurs much more rapidly, with -the-
po3sible /
xa9 ai nst staph u 2 b
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Table 5:2
KILLING OP STAPHYLOCOCCUS 42b BY FIVE ANTIBIOTICS




























Normal males 7.2 0.95
Normal females 12.7 1. 54
Infected males 2.9 0.88




possible exception of tobramycin. This is very
important since it suggests that, in vivo, the
majority of bacteria will be intracellular before
these antibiotics have acted. Unless the antibiotic
enters the cell with the bacteria or can diffuse
freely into the cell, it has little opportunity
to destroy even such sensitive strains as
staphylococcus 42b.
There are no systematic studies of the cell-
associated levels of these five antibiotics.
Saggers & Lawson (1970) found about 2fo of the
extracellular concentration of cloxacillin associated
with lymphocytes. Alexander and Good (1968) and
Mandell (1973) concluded that most antibiotics
could not enter phagocytes since they could not
show effects on intracellular bacteria. Our own
studies, which utilised micro-methods to assay
antibiotic in mixed leucocyte preparations (Raeburn
et al, 1976), show a different picture (Table 5:3).
The important difference is that we assayed the
cell concentrations directly, without washing,
since this must remove some cell-associated antibiotic.
Even allowing for some contamination of the cell
layer by supernatant, our findings suggest that






MIXED LEUCOCYTE LEVELS QE AMPICILLIN
AND TOBRAMYCIN
Incubation Cell concentration in mg/1
time (mins) (% supernatant)
AMPICILLIN TOBRAMYCIN
0 1.9 (67) 0.7 (22)
$0 2.5 (74) 1.9 (62)
60 2.4 (80) p#1 (71)
120 1.7 (61) 1.0 (35)
240 2.0 (66) 0.8 (24)
x
Details of the technique are in appendix 6,
page 213•
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than has been hitherto suggested.
Comparisons of the antibiotic killing indices
and the bactericidal indices from normal subjects
show that two of the antibiotics tested, clindamycin
and fucidin, are less active against staphylococcus 42b
than are normal granulocytes. However, the difference
is not large. For patients with chronic granulomatous
disease, or those with impaired killing during an
infection the antibioticb effect could be of critical
value. Such antibiotic activity will be maximal in
the extracellular situation, complementary to the
intracellular killing within the granulocytes.
Such comparisons of the rates of bacterial
killing assume that antibiotics and phagocytic
cells do not interact and that their effects are
additive. However, phagocjrtic cells may interfere
with antibiotic actions (Ritzerfield, 1974) and vice
versa (Forsgren et al, 1974). Possible interactions
could either enhance or inhibit the rate of
bacterial killing. To examine this aspect the
following experiments involved the measurement of
phagocytic and bactericidal activities of granulo¬
cytes in the presence of antibiotics which were
administered either in vitro or in vivo.
147.
BACTERIAL KILLING BY PHAGOCYTIC CELLS
PLUS ANTIBIOTICS
METHODS
1. Antibiotics added in vitro
In these experiments ampicillin (5mg/l,
final concentration) was added to the leucocyte/
bacteria mixture in normal clinical dosages after the
30 minute period for phagocytosis and the washing
stage. The killing assay was then performed in the
usual wayx. For each experiment a control cell/bacteria
mixture was incubated without antibiotic. In one further
test the ampicillin was inactivated using penicillinase
for 5 minutes prior to lysis of the cell button.
(Table 5:4)
2. Antibiotics administered to human subjects
i) Measurements of phagocytosis and intra¬
cellular killing were performed on 5 patients
undergoing treatment for a chronic respiratory
infection. Each patient was roughly matched with
a comparable individual who was not receiving
antibiotic therapy. Olinical details and the
results are shown in Table 5:5.
ii) Measurement of phagocytosis and intra¬
cellular killing was performed serially in 6
patients/
x See appendix 6 page 218.
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Table 5:4
AMPICILLIN AND INTRACELLULAR KILLING
BY GRANULOCYTES
(In vitro effects alone and combined)
Bactericidal
Experiment Test Mixture index S.E.M.
1 a) Normal cells 14.1 1.9
b) Normal cells +
ampicillin* 12.6 2.6
c) Normal cells +
ampicillin*
(+ penicillinase) 14.2 3.8
2 a) Normal cells 11.3 3.3
b) Normal cells +
ampicillin* 9.0 1.2
3 a) Normal cells 37.0 4.1
b) Normal cells +
ampicillin* 30.9 3.6
c) Ampicillin alone* 25.8 6.0
* Final concentration in mixture 5 mg/l.
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Table 5:5
PHAGOCYTOSIS & KILLING IN ANTIBIOTIC TREATED
X
PATIENTS AND MATCHED * (UNTREATED) CONTROLS
Bactericidal
Diagnosis Sex Antibiotic Age Ti index
Chest infection F Penicillin 73 3.8 2.1
Chest infection F Nil 72 4.0 4.0
Chest infection M Septrin 4 4.1 1 .0
Chest infection
+ candidiasis
M Nil 4 6.0 10.0
Chest infection
+ asthma
M Ampicillin 58 9.5 10.0
Chest infection
C.L.L.
F Nil 60 6.5 16.0
Chest infection F Ampicillin 40 10.6 3.2
Behcets synd.
+ chest infection
M Nil 44 7.0 6.2
Cystic fibrosis
+ chest infection
M Ampicillin 12 5.6 4.3
Cystic fibrosis F Nil 15 5.2 10.0
+ chest infection
GROUP ^Conditions and methods as in Table 4:4
Mean T4 S.E.M. Mean Bact. S.E.M.
Index
Antibiotic treated 6.7 1.4 4.1 1.6
Untreated 5.7 0.5 9.2 2.1
* In these preliminary experiments the patients in the
treated or -untreated groups were not all matched for
sex (see Chapter 4, Table 4:4).
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patients who were either on or off antibiotic
therapy. The clinical information and the results
are in Table 5:6.
iii) Four healthy volunteers received ampicillin
(500 mg) orally after a control blood sample had
been taken. Further blood samples were taken at 1,2
and 3 hours after this single dose. Each sample was
immediately heparinised (final heparin concentration
was 10 units per ml.) and subdivided as follows for
various cell or plasma assays









8 mis - plasma - ampicillin
assay
1.5 mis - Resting/stimulated
nitro-blue tetra-
solium test**
* Performed by Mrs. Marjory Grant & Dr. Angus Harkness
** Performed by Dr. Kenneth Watson
x for methods see appendix 6, pages 213 - 215.
Table5:6
COMPARISONFT4-PHAGOCYTOSISNDKILLI GIND CESWHILE ONRQFFANTIBIOTIC







onfp 4.0 5.0 5.4 6.2 3.7











Tables 3:4 - 9 and figures 5:2 & 5:3 summarise
the results of these studies of the combined action
of antibiotics and phagocytic cells.
When ampicillin was added in vitro there was
no significant alteration in the intracellular
killing activity (Rig 5:2 and table 5:4).
Table 5:5 shows the clinical details in five
pairs of patients who were either on or off antibiotics
at the time of the test. These patients were not
completely matched and the differences in bacter¬
icidal index have not been statistically analysed.
However, those receiving antibiotics tended to have
lower bactericidal indices.
The patients who were tested twice, first
during antibiotic therapy and then when treatment
had been discontinued, tended to have lower
bactericidal indices (table 5:6). During treatment
one.individual had a higher bactericidal index while
receiving ampicillin but she had a variety of complex
X
medical problems. All the other patients had
lower indices when receiving the antibiotic.
These initial studies pointed to a possible
influence /
153.
EFFECT OF AMPICILLIN IN VITRO UPON INTRACELLULAR
KILLING OF STAPHYLOCOCCUS (42b)
Figure 352 The effect of ampicillin (5ng/l final
concentration) upon intracellular killing by
granulocytes.
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Figure 5:5 Mean bactericidal index (right hand
scale) in 5 healthy subjects at various times after




influence of several, antibiotics given in vivo,
upon the intracellular killing by granulocytes.
To clarify the effect, studies were performed on
healthy subjects who received single oral doses
of ampicillin. These were supplemented by enzyme
assays performed by Mrs. Marjory Grant, Dr. R.A.
Harkness and Dr. K.C. Watson.
The mean bactericidal indices measured serially
after ampicillin was given in vivo to 3 healthy
subjects, are shown in Fig 5:3. Table 5:7 shows
the individual results in 4 male subjects at each
hourly sampling period following ampicillin, and
the means. Despite widely differing starting points,
all subjects showed a fall in the bactericidal
x
index at 1 and 2 hours followed by a rise at 3
hours towards normal.
The individual results for leucocyte myelo¬
peroxidase activity and the plasma ampicillin
levels are in table 5:8. As the amp.icillin level
rose the leucocyte myeloperoxidase activity fell
but there was a tendancy for the 3 hour level to
Corre spondinq
overshoot the control value y\ results for
leucocyte catalase activity and for the increments




BACTERICIDAL INDICES IN 4 HEALTHY SUBJECTS TOO
RECEIVED A SINGLE ORAL DOSE OF AMPICILLIN (5QOmg)
Time after dose (Hours)
Sub.ject Age 0 1 2 5
J.A.R. 53 17.5 3.1 0.5 11.8
P.P. 29 19.0 8.1 5.1 16.0
A. S. 27 6.2 0.2 2.0 4.0
D.V. 27 12.4 2.5 3.4 12.6
MEANS 13.8 5.5 2.5 1 1.1
S.E.M. 2.8 1.7 0.7 2.5




MYELQPEROXTDAS3 ACTIVITY*(M.P.O. UNIT3/MC& PROTEIN)
IN 4 HEALTHY SUBJECTS AETER 5QOMG AHPICILLIN
Time after dose in hours
xx
Subiect 0 1 2 1
J.A.R. 5.0 3.6 4.4 6.2
P.P. 1.1 0.92 0.92 0.37
A.S. 0.98 0.49 0.51 1.5
D.V. 1.1 0.85 1.61 2.1
X
MEANS 2.05 1.47 1.70 2.54
X
(b)
AXPICIUIN LEVELS (K&/L) IN HEALTHY SUBJECTS APT3R
500 MO ORALLY
Time after dose in hours
Subject 0 1 2 5
J.A.R. 0 4.9 4.5 3.3
P.P. 0 1.0 2.C 4.2
A. S. . 0 0.8 2.1 2.6
D.Y. 0 10.8 30.5 13.4
MEANS 0 4.4 9.8 5.9
* MEASURED BY MRS. M. SHAN'T & DR. R.A. RARENESS.
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stimulation of the heparinised whole blood samples
X
with Escherichia Coli) are shown in Table 5:9.
DISCUSSION
The antibacterial,activities of phagocytic
cells and of antibiotics can be measured in vitro
and compared. From these separate measurements it
seems that the activity of phagocytic cells against
staphylococcus 42b is of a greater magnitude than
that of most antibiotics studied (Tables 5:1 and
5:2). In the in vitro study using a mixture of
granulocytes and ampicillin, (Fig 5:2, Table 5:4)
there was no evidence of a change in the bactericidal
index produced by that agent. In vivo the
situation may be different.
The first indication of an interaction between
granulocytes and antibiotics was that the bacter¬
icidal index was apparently reduced in those
infected patients who received antibiotics compared
to those who did not. (Table 5:5). A similar
suggestion stems from the repeat assays of phago¬
cytosis and killing in individual patients (Table
5:6). In both instances the granulocyte activity
which altered was the intracellular killing rate
and/
x for methodology please see appendix 6, page 213.
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Table 5:9 (a)
CATALASB ACTIVITY (MOLES x 10~13/g PROTEIN)*
IN 4 HEALTHY SUBJECTS AFTER 5QOMG AMPICILLIN
Time (Hours)
Subject 0 1 2 5
J.A.R. 5.0 4.4 2.4 2.6
P.P. 1.5 5.1 5.7 5.6
A. S. 1.5 2.2 2.4 5.5
D.Y. 0.8 1.0 0.9 1.2
MEANS 1.7 2.7 2.4 5.2
Catalase activity was significantly raised in three
individuals, particularly at 3 hours after administration
of ampicillin
(b)
INCREMENT OE N.B.T. REDUCTION (#)** AFTER







J.A.R. 28 16 10 51
P.P. 26 70 22 24
A. S. 15 1 25 25
D.Y. 11 N.D. 1 N.D.
MEANS 20 29 15 26
X
Coefficient of variation of 2 control samples in each
individual = 7fo
* MEASURED BY MRS. MARJORY GRANT AND DR. R.A. HARKNESS
** MEASURED BY DR. KENNETH WATSON
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and not phagocytosis. .However, these findings are
based on snail numbers of tests in widely varying
clinical situations. The obvious bias is that a
patient receiving an antibiotic is likely to be
'more infected' than one who is not and infection
itself may cause a drop in intracellular killing
(Chapter 4, and Solberg & Helium, 1972).
The sequential tests of bactericidal function
in normal individuals who received a single dose
of ampicillin were planned so that the effect of
infection could be excluded. The hydrogen peroxide
- myeloperoxidase - halide system is so important
in intracellular killing that the study was conducted
in collaboration with colleagues who could examine the
different aspects. The individual results for
intracellular killing or for each of the enzyme
systems, show that oral administration of 500 mg
of ampicillin leads to a change in the measured
activity. In isolation, the results in each test
are of interest but of uncertain significance.
Taken as a whole they suggest that ampicillin acts
on a series of important and inter-related metabolic
pathways of the leucocyte. Thus it has already
been shown that penicillins in vitro inhibit
peroxidases/
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peroxidaseSof vegetable origin (Renz etal, 1972)
and also human myeloperoxidase (Grant 1 Harkness,
1976). In addit ion, there have been occasional
reports that administration of an antibiotic to
an injected patient causes the percentage of IT.3.1.
positive neutrophils to fall (Rubinstein et al,
1973, Hawkins, 1973), which could reflect diminished
hexose monophosphate shunt activity end hence a
reduction in available hydrogen peroxide. Both
effects would interfere with the myeloperoxidase
killing system and when combined one might anticipate
reduced intracellular killing, of the degree that
has been described (Table 5:7).
The effect on catalyse is difficult to explain
particularly since the in vitro studies show that
in concentrations of 0.1 m.mol/l, ampicillin inhibits
this enzyme (Renz et al, 1972). In vivo the
concentrations assayed in our test subjects were
between 0.01 and 0.03 m.mol/l, and some stimulation
may occur at sub-inhibitory concentrations. What¬
ever the mechanism, an increase in leucocyte catalase
would more rapidly destroy hydrogen peroxide and further
hamper the myeloperoxidase bactericidal system.
Figure /
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Figure 5:3 demonstrates that as the plasma
level of ampicillin rises there is a fall in the
bactericidal index. At three hours however, the
index has risen while the ampicillin levels persist.
There are several possible explanations for this
phenomenon but the simplest would be that ampicillin
has seeped into the phagosomes of the cells after
three hours. Mandell (1973) has suggested that
most antibiotics, with the exception of rifampicin,
are unable to enter phagocytic cells. His detailed
studies did not include ampicillin but they suggested
that unless an agent is highly lipid soluble (and
ampicillin is not) it is unlikely to penetrate the
cell membrane. Our studies show that ampicillin can
apparently act on myeloperoxidase (situated in the
primary lysosomes), on catalase (in cell membranes
and other subcellular fractions) and possibly on the
hexose mono-phosphate pathway (in the mitochondria
of the cell sap). The only convergence of these
enzyme systems occurs within the phagolysosome
formed following phagocytosis. It is therefore
pertinent that there is an effect on intracellular
killing. Ampicillin inside phagolysosomes would
not itself demonstrate antibacterial activity if
the pH at that site were unfavourable (optimal pH
for/
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for ampicillin's antibacterial action is around
6.5). Intracellular pH is still something of a
controversy but Sprick (1956) has suggested that
within the phagosome it can fall to between 4.7
and 5.5.
All of these assays are subject to a variety
of technical problems. In particular it is difficult
to measure the rate of intracellular killing,
sequentially, at hourly intervals. It is relevant
that the coefficient of correlation between the
logarithm of the viable bacteria and the duration
of intracellular incubation dropped at the 1, 2 and
3 hour sampling times. Perhaps the presence of
antibiotic affects the precision of viable counting.
These studies must be repeated in far larger groups
and with more precise techniques.
The experiments in this chapter have assumed a
very simple model for neutrophil/staphylococcal inter¬
action. After 30 minutes a few percent of the initial
inoculum will remain extracellular and some will
divide. In addition, some of the neutrophils which
ingest the organism will not survive and will even¬
tually release viable bacteria. These two processes
will cause there to be a continual low proportion of
extracellular bacteria and it is on these that anti¬
biotics will have their principal effect.
164.
SUSfrlARY
1. Ill cell-free preparations the rate of "bacterial
reduction "by four out of five antibiotics was much
less than the rate at which phagocytes ingest
bacteria.
2. Clindamycin, cloxacillin and cephalexin could
kill staphylococcus 42b at about the same rate as
that of intracellular killing. Fucidin was much
less rapid than intracellular killing. Tobramycin
was much more rapid than intracellular killing.
3. In mixtures of phagocytic cells and ampicillin
in vitro the antibiotic did not appear to influence
the rate of phagocytosis or of intracellular killing.
4. When certain antibiotics are given to either
patients or healthy subjects in vivo. there may be
a reduction in intracellular killing.
5. This is probably caused by the inhibition of
myeloperoxidase and of oxidative enzymes, as well
as by effects on catalase.
6. These findings are of considerable clinical
importance and require elucidation and confirmation.
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nine relevant questions md conclusions
CHAPTER 6
» now to perform a true physician part
and show I am a master of my art,
I will prescribe what diet you should use,
what food you ought to take and what refuse."
(Ovid, c 10 B.C.).
WHY IS INEBCTIOX PREVALENT DESPITE
MODERN ANTIBIOTICS?
Since the introduction of antibiotics into
clinical practice there has been a dramatic fall
in the morbidity and mortality caused by many
infections. The principle change has been a lower
death rate due to acute infections such as pneumonia,
pyogenic meningitis or scarlet fever (Office of
Health Economics 1962, 1963), and the use of chemo¬
therapy must have been a major factor (Garrod,
1970). However, for many acute infections, such
as diphtheria or whooping cough, the fall in the
death rate preceded the use of antibiotics, and
public health measures such as immunisation or
improved /
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improved social conditions were also of great
importance.
Nowadays, despite a great abundance of antibacterial
agents, bacterial infection remains very common
(Sabin, 1970). Many infections become chronic
and their protracted course testifies to the failure
of modern therapy in such circumstances (Cluff et al,
196S). Since the antibiotics administered are
often highly active against the infecting pathogen
in vitro, there may be some inherent limitation of
our present day regimes. Nor example, in chronic,
localised, infection, it is clearly important that
the drug is distributed to the site of infection
and one finding in this thesis is that this
principle applies as much at the sub-cellular level
as it does in individual tissues. If the chosen
antibiotic is to complement the phagocytic cells,
which have rapidly ingested the infecting organisms,
it must be able to penetrate and exert its anti¬
bacterial effects in the phagocytic vacuole.
Most investigation of refractory infections
has centred around the degree of sensitivity or
resistance exhibited by the causative organisms.
In addition tnere have been some studies of anti¬
biotic /
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antibiotic localisation in special sites, eg. in
sputum (Campbell 1970, May 1972), or in infected
<
vrounds (Ellis et al, 1975 )• Very few studies have
focussed on the problem of the combined antibacterial
action produced by the host defenses when they are
"augmented" by antibiotic therapy. Perhaps the
clinical irnmunologist, the clinical microbiologist
and the clinical pharmacologist have moved too far
apart. In my clinical work I have seen infected
patients whose pathogen was extremely sensitive to
the antibiotic administered. Furthermore it was
possible to demonstrate that the drug was absorbed
and that it reached the site of infection. Never¬
theless some such patients did not respond to
therapy. Immunological investigations before, during
and after courses of antibiotics seemed to be a
possible approach to the problem.
WHY STUDY PHAGOCYTIC CELL3?
The range of leucocyte activities which occur
in response to invading bacteria is so great that
to select for study one specific function of one
group of cells may lead to false conclusions. This
is /
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is because the different branches of the immune
system are co-ordinated in such a way that a
healthy balance is maintained, for example,
?l. KcG- a boy of 7 with chronic granulomatous
disease (page117) had raised immunoglobulins
(igG = 2600mg/l00ml., IgA = 1000 mg/100 ml.,
IgM = 365 mg/100 ml.) and these would, to some
extent, have helped to control bacterial infections.
Neutropenic patients, and those with long-standing
defects of intracellular killing, often show a
compensatory increase of immunoglobulins. There
is, however, no evidence that the reverse occurs,
i.e. that phagocytic cells can increase their rate
of phagocytosis or of intracellular killing in
response to a primary defect of lymphocyte function.
When this project was planned it was thought
that measurements of phagocytic cell function
t
during antibiotic therapy would show increases in
the antibacterial activity and that this would be
attributable to the effect of antibiotics. The
influx of antibiotics and of phagocytic cells from
the blood stream to the site of infection had
obvious similarities, and could be qualitatively
compared (Chapters 2 and 3). In addition, a study
of /
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of the anti-bacterial activities of phagocytic cells
was defended on physiological grounds, since these
cells are the first to participate in the reaction
to infection, comprising over 95fa of the cells
present in the first 24 hours of inflammation
(Chapter 2, Hurley 1972).
WHAT HAPPENS TO T3UT50PHILS DURING IH7ICTI0N?
Localised infection caused by pyogenic bacteria
initiates an inflammatory response'which is very
similar to the skin window reaction. The measurements
of Chapter 2 show that normal subjects can achieve
concentrations ranging from 2 x 10^" phagocytic cells/
ml serum (in the first 3 hours) to 4 x 10 /ml serum
(averaged over 24 hours). My findings indicate a
slightly lower leucocyte mobilisation rate per unit
area than was reported by Perillie & Pinch (1964)
or Senn et al, (1969). However, these groups both
used autologous serum in the skin chambers, while
I used plain medium 199. The serum could well have
contained chemotactic factors which would increase
the rate of cellular response. In contrast to the
normal subjects, neutropenic patients or those with
leukaemias achieve much lower cell concentrations.
Chapter /
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Chapter 4 reports the anti-staphylococcal,
phagocytic and bactericidal activity, measured using
neutrophils in a concentration of 5 x 10^/ml., (a
concentration attainable in acute inflammatory
exudates).
Both phagocytosis and intracellular killing
are functions which are biologically important.
I have found, as did Solberg & Helium (1972), that
during infection the intracellular killing of
staphylococci is decreased without there being
any effect upon phagocytosis. This phenomenon must
be due to a serum factor, since it is measured in
peripheral blood neutrophils which have not yet
encountered bacteria in the infected site. McCall
et al, (1973) studied the metabolic perturbations
occurring in toxic neutrophils from patients with
febrile illnesses and showed an increase of the
hexose monophosphate shunt activity and of the
oxygen utilisation following phagocytosis. Unfortunately
their study did not include measurements of intra¬
cellular killing. They could not show any factor
in the serum of these patients which produced
similar metabolic changes in the neutrophils from
control subjects. Whatever the cause, the reduced
intra/
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intracellular killing of staphylococcus might be
expected to lead to a higher risk of superinfection
with that organism
DO AJfTIBIOTICS SNTSH AR5A3 0? Ih?LAMI>IATIOIT?
Chapter 3 shows that it is possible to demonstrate
antibacterial activity in those inflammatory exudates
which are provoked shortly after the administration
of an antibiotic. It is unwise to place too much
stress on the individual antibiotic concentrations
in the exudates or on the differences between the
various drugs examined. However, antibiotics enter
the exudate before many of the phagocytic cells have
accumulated. The clinical consequence would be that
whenever a patient, who is receiving an antibiotic,
develops some secondary focus of infection and hence
inflammation, he may achieve bactericidal concen¬
trations of the antibiotic in that site before the
phagocytic cells have localised.
WHERE) DO ANTIBIOTICS ACT Id VIVO?
Measurements of the anti-staphylococcal action
of the five drugs studied in Chapter 5 showed that
in general this process was much slower than the
rate /
rate of phagocytosis. Thus unless these antibiotics
can enter phagocytic cells their action would be
confined to the inhibition or killing of the few
bacteria which remain in the extracellular situation.
Mandell (1973) believes that only those antibiotics
which are highly lipid soluble (eg. rifanpicin) can
enter phagocytic cells, basing this view on the
failure to reduce intracellular bacteria even in
the presence of high concentrations of water soluble,
anti-staphylococcal drugs, (intrinsic killing by the
neutrophils was blocked by high concentrations of
hydrocortisone). Even if a significant concentration
of antibiotic penetrates the cell, its action will
depend on the local intracellular conditions such
as pH. The tests in the in vitro system at pH 7.4
(tables 3:1 & 5:2) may not therefore be relevant.
There is some evidence that bacteria exposed
to antibiotics prior to phagocytosis may be damaged
(but not killed) so that subsequent intracellular
killing by neutrophils is increased. (Alexander &
Good 1963, Seneca & Peer 1966). This aspect has
not been followed up in this thesis since it is
difficult to set up in vitro models which reflect
the changing in vivo situations.
DO ANTIBIOTICS ACT ADVERSELY UPON /
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DO ANTIBIOTICS ACT ADVERSELY UPON
NEUTROPHIL FUNCTION?
The initial comparisons of infected patients,
both treated and untreated, suggested that, during
therapy, intra-cellular killing is reduced. This
occurred with various antibiotics. Furthermore,
sequential tests in individual patients tended to
confirm this phenomenon. Only one patient had
increased intra-cellular killing while receiving
an antibiotic and she-had multiple pathology (Table
5:6).
It has not been possible to investigate this
aspect systematically but a series of detailed
studies with ampicillin have shown that oral
administration of that drug to healthy subjects
leads to reversible intracellular effects. The
likely sequence is that some ampicillin enters the
cells and causes inhibition of both myeloperoxidase
and the enzymes of the hexose monophosphate shunt.
Concomitantly there may be increased catalase
activity. During these enzyme changes, and possibly
because of them, there is a reduction of intracellular
killing of staphylococci (Tables 5:7, 5:8 & 5:9).
Such /
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Such intracellular effects would only have clinical
significance if the killing defect affected organisms
which are not sensitive to ampicillin or if the
changes were irreversible after prolonged therapy.
If the pathogens were ampicillin sensitive, any
reduced intracellular killing by the neutrophils
would be compensated for by .the action of that
antibiotic. Apart from the immunological effect,
all these findings tend to weaken Mandell's suggestion
that ampicillin and similar antibiotics cannot
penetrate neutrophils. (Mandell 1973).
IS THE BFTECT 0? AMPIGIL1IN Oil NEUTROPHILS UIIIQUE?
Hoeprick 3c Martin (1969) studied the in vitro
effect of tetracycline, polymyxin B and rifampicin
on phagocytosis (assessed morphologically) and intra¬
cellular killing (studied in a much simplified
technique compared with my own). They stated that
neither phagocytosis nor killing was affected by these
drugs in therapeutic concentrations or even at
concentration ten to one hundred times higher. As
stated in Chapter 4, morphological studies do not
assess phagocytosis accurately. I have analysed
their data for intracellular killing using my own
techniques /
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techniques and find that the bactericidal indices
without antibiotics ranged from 14 to 17. With the
antibiotics at therapeutic concentrations the
indices were 11.5, 11.6 and 8.3 for tetracycline,
polymyxin B and rifampicin respectively suggesting
some fall in bactericidal ability.
Forsgren et al (1974) studied the phagocytosis
of baker's yeast by human leucocytes incubated
in vitro with various concentrations of either
doxycycline or tetracycline hydrochloride and showed
that at concentrations exceeding 3.1 mg/l there was
a significant fall in the percentage of granulocytes
which were phagocytic. In addition they showed
that this phenomenon occurred when healthy volunteers
took tetracycline. Seneca & Feer (1966) studied the
in vitro effect of a wide range of antibiotics upon
the phagocytosis (but not intracellular killing)
of fVoteus vulgaris and Streptococcus haemolyticu3
(Group A). Tetracycline and streptomycin reduced
the phagocytosis of both organisms, but only high
concentrations (62.5 mg/l and above) were tested.
At levels of 250 mg/l, penicillin slightly reduced
phagocytosis of the streptococci.
Alexander & Good (1968) studied the effect of
several /
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several antibiotics in vitro upon the intracellular
killing of Staphylococcus aureus. The antibiotics
studied (which included ampicillin, tetracycline and
erythromycin) had no effect on intracellular organisms
but with penicillin G- there was evidence" that some
organisms were damaged by the antibiotic, but not
killed, and that they subsequently were more sus¬
ceptible to phagocytosis. A criticism of their
technique is that viable counts of intracellular
bacteria alone were not made, only the combined
counts which included extracellular and cell surface
adherent bacteria.
DO TH355 PIHDIITG5 HAVE MIT 01111011 3ICEI1ICAHC2?
Fungal infections, especially with Candida species,
are common complications of antibiotic therapy,
particularly with penicillins (Seelig 1966). Candida
infection seems to occur far more often than other
similarly ubiquitous micro-organisms which are also
antibiotic resistant. Human resistance to Candida
principally involves phagocytosis and intracellular
killing via the myeloperoxidase system (Lehrer 1972)
and therefore all the changes shown in Tables 5:8
and 5s9 would be expected to increase the susceptibility
to /
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to that fungus. The most definitive evidence in
this situation would be if phagocytic defects could
be shown in those individuals who develop Candida
superinfection following the administration of a
narrow spectrum penicillin.
The common explanation for superinfection
during antibiotic therapy is that drug-resistant
species have been selected. This is easily
demonstrable but selection may not be the only factor.
Drug-resistant species would proliferate much more
ra^pidly if there was a concomitant immunological
defect. Thus Speller et al (1976) have studied the
epidemiology of infection due to a gentamicin-resistant
staphylococcus, in surgical and intensive care wards.
Colonisation was much more likely to occur in patients
receiving antibiotics. Similarly Tillotson &
Finland (1968) and Philp & Spencer (1974), showed
that secondary pulmonary infections following anti¬
biotic therapy were often caused by 51aphy1ococcus
aureus, Slebseilla pneumoniae or Pseudomonas aeruginosa.
Defence against these three species is in large




Immunological effects of antibiotics would also
cause infection to occur in sites far distant from
the primary focus, Kangi et al (1973) described
five patients in whom pyogenic meningitis developed
while they received cephalothin for infection else¬
where. In all five cases the organism isolated
from the cerebrospinal fluid (C.S.P.) was sensitive
to cephalothin. Discussions of this phenomena were
centred around the possible stimulant effect of sub¬
inhibitory concentrations of the antibiotic in the
C.3.F. However, it has been stated that "something
seems to be missing in the argument about the
causation" (British Medical Journal, 1973). Perhaps
cephalothin also affects phaocytic cell function 11
ARE 0TI-I3E IHMUHOLOGICAI RB3P0HSE5 AFFBCThD
BY ANTIBIOTICS?
There are scattered references in the literature
to other immunotoxic effects of antibiotics (Tarnowski
& Batko 1973). These have mainly concerned reduced
antibody formation (in experimental animals),
following administration of several antibiotics,
including penicillin, tetracycline and chloram¬
phenicol (eg. Slanetz 1953, Watson, 1959, Siefert
et al /
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Siefert et al, 1971). Stevens (1953) showed that
penicillin and several tetracyclines given to
rabbits slowed the rate of removal ox" radio-
labelled bovine gamma globulin. In addition, it
has been known for many years that antibiotic therapy
of acute infections will reduce the antibody levels
ultimately attained (Daikos & Weinstein, 1951,
Siegel et al, 1961). All these reports raise the
suspicion that antibiotics interfere with the human
response to infections. Recognition of the clinical
sequela.e of such "inmunotoxic" effects might well
be disguised as antibiotic resistant or chronic
granulomatous infections. A further difficulty in
interpreting such phenomena is that many in vitro
tests of immune function involve short term tissue
cultures in which penicillin and streptomycin are




A series of experiments have been carried out
to compare the efficiency of human phagocytic cells
and of several antibiotics in controlling staphy¬
lococcal infection. Neutrophils, 'skin window
macrophagesh, and several antibiotics can be demon¬
strated in acute inflammatory exudates but the
kinetics of their localisation in the test site
is very different. In vitro models have been
exploited to measure the rate of phagocytosis and
of intracellular killing so that these functions
of phagocytic cells can be compared with the
inhibitory or bactericidal actions of antibiotics.
In general phagocytosis is very rapid, much more
so than the action of antibiotics. Intracellular
killing is a slower process roughly comparable to
the bactericidal effects of anti-staphylococcal
agents such as cloxacillin.
An unexpected finding was that when administered
to human subjects in vivo certain antibiotics
appeared to have adverse effects upon neutrophil
function. In the case of ampicillin this was studied
by serial measurements of'intracellular killing,
neutrophil /
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neutrophil myeloperoxidase and cataiase in normal
subjects who received a single dose of 500 mg.
This showed that ampiciilin has actions upon the
enzymes which would adequately explain a diminution
of intracellular killing.
There are several clinical situations which
would be explicable by such in vitro phenomena.,
and some defects of the conventional explanations
have been summarised. If other antibiotics have
1immunotoxic' effects similar to ampiciilin a
change in present day antibiotic policies would
be indicated. At the very least the findings
provide further important reasons for reducing the
over prescribing,of antibiotics and for deprecating
their use in mild, self-limiting infections.
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APPENDIX 1
COITARISCIT 0? VARIOUS CYTOCNEFIgAL AND FUNCTIONAL
PROPERTIES 0? TiOITOCYTIO CELLS IDT 52IN WINDOWS AND
IN THE PERIPHERAL BLOOD
These experiments were performed to identify the
origin of "skin window macrophages". Since in the mouse
model, macrophages are derived from blood monocytes
(van Furth and Cohn, 1968), we studied human blood
monocytes (see method -2, page 103) as well as skin
window cells during in vitro culture. Table A:1 shows
the results and confirms the great similarity between
the two types of cell. Taken in conjunction with in vivo
labelling studies (Whitelaw 1975) and with the animal
models, it seems almost certain that skin window macro¬
phages in man are derived from blood monocytes.
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Table A:1
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These results show that my assay system is
fairly accurate at the upper limit of the therapeutic
range. However, lower concentrations are under¬
estimated and there is a degree of 'drift'.
* See Beeves & Bywater (1975)
** Serum also contained lincomycin.
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APPENDIX 3
antibiotics in ixflaidlatoxy exudates -
coaascTioiT factors
The weight of exudate produced in each hourly-
collection after antibiotic administration varied
from about 5 nig to 20 mg. Initially these were
assayed against standards placed on identical assay
discs which were then fully saturated (weight taken
up was around 35 nig)'. Subsequently a series of
assays were performed using standards of 10 mg,
20 mg, 25 mg or 30 mg and when these were plotted
an approximate correction factor could be obtained.
Figure A, 3:1 shows a typical correction graph
(for cephalexin). It is clear that a level read
off using 30 mg standards from an exudate sample
weighing 10 mg, would be grossly underestimated.
Figure A 3:2 shows these results for cephalexin
by plotting the zone of inhibition against weight
of standard at each level of antibiotic. Clearly
these are not straight line relationships and the
use of simple multiplication to correct for the
differing exudate weights would be quite wrong.
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CORRECTION GRAPH FOR CEPHALEXIN
Zone Diameter (mms)
Figure A 3'-l Log-plot of cephalexin concentration
against zone diameter. The original
result for an unknown sample is read
off and the zone diameter (D) for that
concentration (with a 30 mg standard) is
found. The nearest weight of standard
to the unknown is then checked for a
diameter of D and the corrected value
is read off.
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10 15 20 25 30
Weight of standard on disc (mg)
Figure A 3:2 Graphs of zone size against weight of
standard for various concentrations
of standard. Note the overall plateau
effect on zone size after weights of 25 mg.
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APPENDIX 4 (a)
sources op media. reagents etc.
Nutrient agar
Buffered physiological saline











A3 serum - pooled from 2 donors
Falcon tubes
Kicroplat.es (M34R)
Filter paper discs (12mm)
Antibiotic Standards:
a) Ampicillin, Penicillin 6b
Cloxacillin
b) Fucidin & mecillinam


















Falcon Plastics Ltd. via
Dynatech, Billingshurst.
Cooke I struments via Dynatech
ast Laboratories Ltd.









APPARATUS USED IN STUDIES
Electric colony counter - Ghiltern (3L30), via
Macfarlane Robson, Glasgow.
Microscope Leitz Laborlex, Leitz,
W. Germany.
C02 incubator Assab Ltd., Sweden
Centrifuge Christ Bench Centrifuge with
14 cm swingout head.
Preparation of Kan-low's reagent (see page 21)
1. 30$ ethyl alcohol 100 ml.
2. Benzidine dihydrochloride
(Fluka, Buehs) 0.3 grams
3. 0.132 molar (3.8$ W/V) Zn S04 .^O 1.0 ml.
4. Sodium acetate (Na C2 O^y^O)
(Merck) 1.0 gram.
5. 3$ hydrogen peroxide 0.7 ml.
6. 1.0 normal, UaOH 1.5 ml.
7. Safranin (Merck) 0.2 grams
Instructions.
Add reagents in the above order from 1 onwards mixing
well each time. There may be inert residue in the
benzidine which does not dissolve. Final PH should
be 6.00 i 0.5.
Filter solution through ordinary "liter paper and store
at room temperature keeping away from excess light.
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Carrier state based on either pedigree or N.B.T. testing.
Pedigree of the family with chronic granulomatous
disease described in Chapter 4 (page 117). R. McG.,
was IV, 5» his sister was IV, 1 and his mother was
III, 2. (see table 4:8).
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APPihDIX 6
i) Details of chambers used for collecting leucocytes
"rom a la windows.
Chamber a was made fro>. the metal top of a
lass universal by embedding two i inch syringe
needles (23 0 diameter) so t .at one needle opened
at the to? , while the other was at the open end and
close to toe s .in surface vien in tor it ion. The
needles were fixed in position by an epoxy-resin
glue (araldite). Chamber b was supplied by Dr.
• I»H« Sheldon of the Johns Hopkins University and
had the advantage of a wider flan e at the shin
surface which minimised leakage of fluid. The
internal <U eter of t ils chamber was 7mm and fluid
was exchanged via polypropylene labia attached to
metal needles. The internal volume of chamber a w°s
2.1 1 and o ' c amber b was 0.5 ml.
ii) abate..an.ce o" icro-o . ■nlsiss.
The organisms used for antibiotHpassays and the
Staphylococcus type 42b were • ai twined or nutrient
agar slopes in lass ijou bottles. Tuese organisms
were sub-cultured every fortnight, incubated for 18
hours at 57^C and then stored at 4°C. On the day
prior /
212.
prior to use they were inoculated into nutrient
broth usin a standard bacteriological loop before
overnight incubation, For antibiotic assays between
0.05 ril and 0.5 nil of tne overni it cultures
(dependent on the degree of growth assessed visually)
was added to eae 100 ml of molten agar (pages 56
and 57).
For studies of phagocytosis - rid intracellular
killing the overni fit cultures of Staphylococcus
tape 42b were ce tri uged (3000 rpm for 10 inutes),
washed twice in sterile saline and resuspended in
Hank's solution plus 0.1% elatine. A. 1 in 10
dilution of t lis solution contained appro*iraa ely
1 x 10: staphylococci per ml. (pa e 103)
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iii) Antibiotic assay in mixed leucocytes
ixed /
213.
ixed leucocytes were prepared by clextran
sedimentation as described on page 103 and brought
to a concentration of 2 x 10 cells/nil in medium 199.
150 ul volumes were added to the wells of round-
bottomed icrotitre plates (JS34&) and at v r'ous
times 50 ul of medium contalnin " either arapicillin
or tobramycin was added to give a. final concentration
in the cell mixture of 2.5 mg/l. 4fter incubation
for varying periodn up to 4 hours the samples were
centri 'uged at 500 x g for 15 minutes and the super-
natants were separated from the cell pellets, doth
supernatants and cell pellets were assayed and the
cell concentration as expressed as a percentage
of tie supernatant value (table 5s3# page 145).
iv) etnod *o: estimation of leucocyte a, eloperoxids.: .e
and catal'se
(Kindly performed by Mrs. harjory Grant & Dr.
H. • Hardness)
ixed leucocytes were obtained from 8 ml hepar-
inised blood (10 units beparin per ml) by dextran
sedimentation as de cribed on page 103. They were
thee; washed twice wit, bu fered saline and centri-
fuged at 100 x g for ten minutes. Contaminating
er.yt rocytes ere removed by differential lysis
using /
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using 2 ml of Q,2> sodium c iloride and after 15
seconds, hypertonic saline was added to restore
isotonicity. If necessary, this process was repeated.
The cell fixture was spun at 100 x g for 5 minutes
and the cell pellet was resuspended in 0.5 mis buffered
saline. The leucocytes were the lysei by freezing
(to - 20°C) and t .awin three times. Debris was
re owed by centri fugatioi at 800 x g for 20 minutes
at 4°C,
■yeloperoxidase ( .P.O.) activity was assayed
at pH 6.0 using orthodianisidine (B. . ,) as substrate
in t le presence of an excess of hydro en peroxide.
The activity was based on the oxidaton of the
substrate, measured spectrophotometrically at 460 nra,
and was expressed as tt.P.O. units per ug protein.
Catalase activity was assayed by measure ent
of the rate of enzyme-catalysed destruction of hydro: en
peroxide (1.25 x 10*"^ M) in 0.01 M phosphate buffer,
using ultra violet srectrophometry. The activity
was expressed as noles catalase x 10~~^/ug protein.
Protein concentrations used in the standard¬
isation of both enzyme activities were determined by
the raetho of Lo r et al, 1952.
v) "eti.od "or w rforr In- t ,e nltro-blue tetr^zolinm
test
(iviridly nor for ed by Jr. K.C, atson)
One /
215.
One tenth ml e arinised wiole lood was mixed
in riero-late wells with an equal volume of 0,2?<
nitro-blue tetrasolium ( .3. .) (Slams,) in saline.
Further wells contained similar volumes of the blood/
VfBT mixture hut in addition 2 loopfuls of an overnight
cullure of Staphylococcus aureus were added. After
mi ••• in? , the preparations were incubated at 37°C for
20 minutes and films were made on ieroscope slides
''•e "ore air dry in . The./ were fixed in for o-
et .a ol for one inute end t ie counter-stained for
10 irmte- usin a 1 in 20 aqueous dilution of
G le s' (iarck).
The stained films were examined under high power
magni ication and trie number of .B.T. positive cells
(containin dark, blue for azan deposits in the cytoplasm.)
out of 100 neutro?oils counted \as recorded,
vl) 0/toc e.leal at iO ased to obtain lata of
• Lc: A:1 (page 184)
Separated monocytes (see pares 103 c 104) were
suspended in median 199 plus 20, inactivated newborn
calf serum ( .B. .0.) (Grand Island Biological Co.,
Grand Island, Jew York), The final cell concentration
as 2.0 x 10^ per ml and 1 ml aliquots w re added to
Lelrhton tubes cont- ining 10 x 35«vn coverslips.
iach /
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JSach tube was gassed with 57 CO-, in air, ti tly
stoppered and the i incubate at 37°C for 6 or 48
hours. The 48 hour preparations had a •••odium charge
at 24 hours.
Skin macrophages were collected on coverslips
(pa? e 26, method l) and wore c lured in 50mm Petri
dishes conta.inin 2 ml of aedium 199 (+ 20$ h.B. .3.)
in a 5'/- (Og incrbator.
i'iaoc;bos Is;
To study this activity in vitro the preparations
were cultured throughout in medium 199 + 20$ ft.B.C.3.
which also contained 100 u /ml dextran sulphate
(il. . 500. .-30, Pharmacia Uppsala, Sweden), hfter
air drying and fixing in the usual ay the preparations
were stained for 4 minutes wit . toluidine blue (IP
in 30$ ret" iol). The proportion of positive cells
(containing many blue stained pinocytic vesicles)
was assessed under hi , power.
Esterase activlty:
The air dried preparations were fixed in for alin
vapour for 60 seconds, washed in distilled water and
dried. The horizontal slides were then covered with
esterase reagent for 25 minutes. The reagent was
prop-red by ixin 8.8 r.l Basic Pucnsin solution
(1.0 /
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(1.0 G in 30 ml 2DT Bydrochlorine acid) with 0.8 ml
sodium nitrite solution (1.0 G in 30 ml water)
After 30 seconds 4.0 ml of 0.40 molar sodium caco-
dylate solution was tuen added rand the pH was
checked. ; ore of the sodium cacodylate solution was
then added until the pH was 6.0 and the volume was
brou ht to 15 ml with distilled water. The: 0.15
ml of 10i^ t\*een 20 was added. This solution was
added to 2 ml of 0.52> (w/v) alpha naphthyl butyrate
(Si -ma ) in dioxane mixed with 3 ml of methanol.
Distilled water was added to a final volume of
40 ml. The reagent was used for up to 6 nours.
After 25 minutes in the reagent at room temperature
the preparations were rinsed, dried and counter-
stained with dilute Giemsa. The proportion of cells
with brown stained cytoplasm was assessed under high
power.
Peroxidase activity:
The air dried preparations were fixed in 10/fe
formalin in absolute alcohol for 1 minute, rinsed
in tapwater and dried, Kaplow's reagent containing
0.3/* (w/v) benzidine dihydrochloride was poured over
the horizontal slides and washed off after 30
seconds. This reagent is table for up to 1 month.
After /
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After drying, the elides were counterstained with
safranin, washed gently and dried. The peroxidase
positive cells contained many blae e toplasmic
granules,
H
In vitro labelling with 3 thymidine:
For t -se stxidies rethyl-labelled tritiated
thymidine (low England Nuclear Corp., Boston, Bass,
specific activity 6, 7 c/m.mole) was in the medium
for the whole duration o" culture in a final
concentration o' 0.1 Curie/ml. In add it"on all
the solutions used to prepare the cell suspensions
from blood contained the labelled thymidine. After
careful washing and fixation in absolute methanol
the slides were dried and prepared for autoradiography
as previously described (van Furth et al, 1973),
using K5 nuclear emulsion (llford Ltd., Essex England)
and kodak 1)19 developer (kodak Ltd., England). All
cells vitu more than 5 grams overlying tie nucleus
were reported as positive,
vii) Methods for studies of antibiotics and
phagocytic cells in vitro. (page 147, 1,)
These experiments v?ere perfor ed using mixed
leucocyte preparations obtained by method 1 (page 103).
Pha ocytosis of Staphylococcus 42b was performed
usin /
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using the established technique (method 2 page 106)
and a 30 minute period of incubation. The mixtures
wore then centrifuged at 100 x g for 5 minuter; and
the cell button was washed twice with heparinised
physiological saline before resuspension in Hank's
solution plus 10$ AB serum to a cell count of 5 x
6 /
10 /ml. The mixture was then split into two and
ampicillin in distilled water (750 m /l) was added
uoirv a amllto- icro syringe to give a final
concentration in one of t e cell mixtures of 5 mg/l.
The two preparations were Incubated f'or a further
2 hours and were sub-sampled for viable counting as
described on page 110. The bactericidal index was
calculated in the usual way. In one experiment the
preparation containing ampicillin was set up in
duplicate and each sub-sample from one tube was
treated with penicillinase ( -.C. 3.5. 2.6) of
staphylococcal origin, at a conce tration of 100
units/ml. In addition t le effect of ampicillin
alone war studied in a cell "ree system.
